Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Dominique Stoppa Lyonnet
Based on 96 articles published since 2008
||||
Expertise Level
The expertise of Dominique Stoppa Lyonnet ranks in the
  • Top 0.39%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 96 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Stoppa-Lyonnet, Dominique   ·   Stoppa Lyonnet, Dominique   ·   Stoppa-Lyonnet, D
Work Locations
Details
Most likely:    Institut Curie      
2019
  • Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Institut Curie, Université de Recherche Paris Sciences et Lettres, Institut National de la Santé et de la Recherche Médicale U 830, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. Electronic address: · Pubmed 30639725
2018
  • Medical Oncology Department, Paul Strauss Cancer Center, Strasbourg Cedex, France. · Service d'Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Consultation d'Oncogénétique, Département de Médecine Oncologique, Institut Gustave Roussy, Villejuif, France. · Service d'Oncologie Médicale, Centre Catherine de Sienne, Nantes, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · Centre de Génétique, CHU, Dijon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Centre Hospitalier Georges Renon, Pôle Oncologie pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Service d'Oncologie Médicale, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Epidemiology and Biostatistics, Paul Strauss Cancer Center, Strasbourg, France. · Cancer Registry of Bas-Rhin, EA3430, Faculty of medicine, University of Strasbourg, Strasbourg, France. · Pubmed 28929593
  • University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America. · Broad Institute, Cambridge, Massachusetts, United States of America. · Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America. · Department of Computer Science, Biomedical Informatics Group Universitätsstrasse, Zürich, Switzerland. · Biomedical Informatics, University Hospital Zurich, Zurich, Switzerland. · Biocybernetics Laboratory, Computer Science Department, University of California, Los Angeles, California, United States of America. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America. · School for the Future of Innovation in Society, and Consortium for Science, Policy & Outcomes, Arizona State University, Tempe, Arizona, United States of America. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · The Global Alliance for Genomics and Health, Toronto, Ontario, Canada. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Centre of Genomics and Policy, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. · Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. · Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, Quebec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Huntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America. · Partners HealthCare Laboratory for Molecular Medicine and Harvard Medical School, Boston, Massachusetts, United States of America. · Graduate School of Medicine, Osaka University, Osaka, Japan. · Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, Québec, Canada. · Center for Biomolecular Science & Engineering, University of California, Santa Cruz, California, United States of America. · Invitae, San Francisco, California, United States of America. · Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America. · National Disease Registration, National Cancer Registration and Analysis Service, Public Health England, London, United Kingdom. · Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts, United States of America. · Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America. · CancerLinQ at American Society of Clinical Oncology (ASCO), Alexandria, Virginia, United States of America. · Institut Curie, Cancer Genetic Clinic, Paris, France. · Department of Oncological Sciences, The University of Utah, Salt Lake City, Utah, United States of America. · Centre of Genomics and Policy, McGill University, Montreal, Canada. · Department of Computer Science, University of California, Santa Cruz, Santa Cruz, California, United States of America. · Institute of Genetic Medicine, Newcastle University, Centre for Life, Newcastle upon Tyne, United Kingdom. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America. · Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. · Swiss Institute for Bioinformatics, Lausanne, Switzerland. · Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Australia. · Pubmed 30586411
  • INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · PSL Research University, Paris, France. · Service de Pathologie, Institut Curie, Paris, France. · INSERM U830, Paris, France. · Service de Génétique, Institut Curie, Paris, France. · Unité de Pharmacogénomique, Institut Curie, Paris, France. · Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie, Paris, France. · CHU Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France. · Unité de Pathologie Gynécologique, Centre François Baclesse, Caen, France. · Service d'Oncologie Génétique, Gustave Roussy, Villejuif, France. · Institut GIMI, CHU de Dijon, Hôpital d'Enfants, Dijon, France. · Oncogénétique, Centre de Lutte contre le Cancer Georges François Leclerc, Dijon, France. · Département d'Hématologie et d'Oncologie Médicale, CLCC Antoine Lacassagne, Nice, France. · Service d'Oncogénétique Régional Poitou-Charentes, Centre Hospitalier Georges-Renon, Niort, France. · Service de Génétique, Clinique Universitaire Saint-Luc, Brussels, Belgium. · Service de Génétique Clinique Guy Fontaine, Hôpital Jeanne de Flandre, Lille, France. · Laboratoire de Diagnostic Génétique, UF1422 Oncogénétique Moléculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Oncogénétique Evaluation familiale et suivi, UF6948 Oncogénétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Laboratoire Maladies Rares: Génétique et Métabolisme, CHU de Bordeaux-GH Pellegrin, Bordeaux, France. · Service d'Oncologie Médicale, Hôpital Universitaire Dupuytren, Limoges, France. · Département de Génétique, Hôpital de la Timone, Marseille, France. · Unité d'Oncogénétique, Centre Paul Strauss, Strasbourg, France. · IUCT Oncopole, Institut Claudius Regaud, Toulouse, France. · Service de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France. · Unité d'Oncogénétique, ICM Val d'Aurelle, Montpellier, France. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · UMR INSERM 1052, Lyon, France. · CNRS 5286, Lyon, France. · Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Université Paris Descartes, Paris, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · PSL Research University, Paris, France. · Pubmed 29665859
  • Supportive Care Department, Psycho-Oncology Unit, Institut Curie, 26 Rue d'Ulm, 75005 Paris CEDEX 05, France. · Psychopathology and Health Process Laboratory, University Paris Descartes, EA 4057, 71 Avenue Edouard Vaillant, 92774 Boulogne-Billancourt, France. · Quality of Life and Cancer Clinical Research Platform, Methodology and Quality of Life in Oncology Unit (INSERM UMR 1098), CHU Besançon, 25030 Besançon, France. · Familial Breast and Ovarian Cancer Centre, Cologne University Hospital and Faculty of Medicine, Kerpener Str. 34, 50931 Cologne, Germany. · Familial Breast and Ovarian Cancer Centre, Cologne University Hospital and Faculty of Medicine, Kerpener Str. 34, 50931 Cologne, Germany. · Supportive Care Department, Psycho-Oncology Unit, Institut Curie, 26 Rue d'Ulm, 75005 Paris CEDEX 05, France. · Cancer Genetic Clinic, Institut Curie, 26 Rue d'Ulm, 75005 Paris CEDEX 05, France. · Clinical and Health Psychology Department, University Autónoma of Barcelona, Carrer de Ca N'Altayó, s/n, 08193 Barcelona, Spain. · Cancer Genetic Clinic, Institut Curie, 26 Rue d'Ulm, 75005 Paris CEDEX 05, France. · Familial Breast and Ovarian Cancer Centre, Cologne University Hospital and Faculty of Medicine, Kerpener Str. 34, 50931 Cologne, Germany. · Supportive Care Department, Psycho-Oncology Unit, Institut Curie, 26 Rue d'Ulm, 75005 Paris CEDEX 05, France. · Centre de Recherche en Épidémiologie et Santé des Populations (CESP), University Paris-Sud, UVSQ, INSERM, University Paris-Saclay, 16 Avenue Paul Vaillant-Couturier, 94807 Villejuif CEDEX, France. · Department 2LPN-CEMA, Université de Lorraine, 23 boulevard Albert 1er - BP 60446 - 54001 NANCY CEDEX, France. · Pubmed 29439543
  • Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil. · Service de Génétique, Institut Curie, Paris, France. · A.C.Camargo Cancer Center, São Paulo, Brazil. · Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France. · Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia. · Université Paris Descartes, Paris, France. · Service de Génétique, Institut Curie, Paris, France. · Gustave Roussy, Villejuif, France. · Pubmed 29236234
  • Institut Curie, Supportive Care Department, Psycho-oncology Unit, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · University Paris Descartes, 71 avenue Edouard Vaillant, 92774, Boulogne-Billancourt, France. · Université de Lorraine, Inter-Psy, 3 Place Godefroy de Bouillon, 54015, Nancy Cedex, France. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Worts Causeway, Cambridge, CB1 8RN, UK. · Institut Curie, Cancer Genetic Clinic, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · Department of Medical Genetics, University of Cambridge, Level 6 Addenbrooke's Treatment Centre Cambridge Biomedical Campus, Box 238, Cambridge, CB2 0QQ, UK. · Department of Clinical Genetics, Laboratory Medicine, Office for Medical Services and Department of Clinical Genetics, Lund University, Universitetssjukhuset, 221 85, Lund, Sweden. · Institut Curie, Supportive Care Department, Psycho-oncology Unit, 26 rue d'Ulm, 75005, Paris Cedex 05, France. · CESP, University Paris-Sud, UVSQ, INSERM, University Paris-Saclay, 16 Avenue Paul Vaillant-Couturier, 94807, Villejuif Cedex, France. · University Paris Descartes, 71 avenue Edouard Vaillant, 92774, Boulogne-Billancourt, France. · Familial Breast and Ovarian Cancer Centre, Cologne University Hospital and Faculty of Medicine, Kerpener Str. 34 I, 50931, Cologne, Germany. · Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, S4-P, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. · Pubmed 28623477
2017
  • Department of Tumour Biology, Institut Curie, Paris, 75005, France. · Inserm U830, Institut Curie, Paris, 75005, France. · Department of Cancer Biology and Genetics, CCC François Baclesse, Caen, 14000, France. · Inserm U1079, Normandy Center for Genomic and Personalized Medicine, Rouen, 76183, France. · University of Caen, Normandie, 14032, France. · Department of Tumour Biology, Institut Curie, Paris, 75005, France. · Inserm U830, Institut Curie, Paris, 75005, France. · Institut Curie, PSL Research University, CNRS UMR3244, Paris, 75005, France. · Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR3244, Paris, 75005, France. · Department of Genetics, Centre Hospitalo-Universitaire, Rennes, 35033, France. · Department of Genetics, Centre François Baclesse, Caen, 14000, France. · Department of Genetics, Centre Hospitalo-Universitaire, Rouen, 76000, France. · University of Rouen, IRIB, Rouen, 76183, France. · Institut Curie, PSL Research University, Paris, 75005, France. · Paris Descartes University, Sorbonne Paris Cité, Paris, 75006, France. · Pubmed 29255180
  • INSERM, U900, Paris, France. · PSL Research University, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Service de Génétique, Institut Curie, Paris, France. · CHU de Lyon, Groupement Hospitalier Est, Service de Génétique Médicale, Lyon, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Institut Claudius Regaud-IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Centre Oscar Lambret, Lille, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · CHU de Poitiers, Service de Génétique Médicale, Poitiers, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Clinique Universitaire Saint-Luc, Génétique, Bruxelles, Belgium. · CHU Clermont-Ferrand site Estaing, Clermont-Ferrand, France. · Institut Bergonié, Bordeaux, France. · Hôpital Saint-Joseph, Marseille, France. · Centre François Baclesse, Unité de Pathologie Gynécologique, Caen, France. · Centre Hospitalier Universitaire de Nîmes, Unité de Génétique Médicale et Cytogénétique, Nîmes, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Centre de Recherche en Cancérologie de Lyon, Lyon, France. · UMR INSERM 1052, Lyon, France. · CNRS 5286, Lyon, France. · INSERM, U830, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 28981872
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England2Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, England. · Centre for Epidemiology and Biostatistics, Melbourne School of Population Health, University of Melbourne, Melbourne, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England. · Centre for Epidemiology and Biostatistics, Melbourne School of Population Health, University of Melbourne, Melbourne, Australia4Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia5Department of Medicine, St Vincent's Hospital, University of Melbourne, Parkville, Australia6Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands8Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England9Mathematics Institute, University of Warwick, Coventry, England. · Centre for Epidemiology and Biostatistics, Melbourne School of Population Health, University of Melbourne, Melbourne, Australia10Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia. · Inserm U900, Paris, France12Institut Curie, Paris, France13Mines ParisTech, Fontainebleau, France14PSL Research University, Paris, France. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah. · Department of Epidemiology, Columbia University, New York, New York. · Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, England. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, England. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, England. · Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, England. · Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, England. · Oncogenetics Team, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, England. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, Scotland. · Department of Clinical Genetics, St George's, University of London, London, England. · Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France28Institut Curie, INSERM U830, Paris, France29Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité d'Oncogénétique, Centre Paul Strauss, Strasbourg, France. · Centre de Lutte Contre le Cancer Georges François Leclerc, Dijon, France32Centre de Génétique, Hôpital d'Enfants, CHU Dijon, Dijon, France. · Centre François Baclesse, Caen, France. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont. · Departments of Pedicatrics and Medicine, Columbia University, New York, New York. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada41Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah. · Human Genetics Group, Spanish National Cancer Centre, Madrid, Spain46Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany48LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Dresden, Germany50National Center for Tumor Diseases, Partner Site Dresden, Dresden, Germany51German Cancer Consortium, Dresden and German Cancer Research Center, Heidelberg, Germany. · Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos, Madrid, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Québec City, Québec, Canada. · Prince of Wales Clinical School, University of New South Wales, Sydney, Australia57Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia58Department of Medical Oncology, St Vincent's Hospital, Fitzroy, Australia. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria61QIMR Berghofer Medical Research Institute, Herston, Australia. · Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Clinical Genetics, Copenhagen University Hospital Rigshospital, Copenhagen, Denmark. · Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · Pubmed 28632866
  • Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge · Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton · Marc Tischkowitz, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge · D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester · Alex Henderson, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne · Carole Brewer, Royal Devon and Exeter Hospital, Exeter · Diana Eccles, Southampton University Hospitals NHS Trust, Southampton · Jackie Cook, Sheffield Children's Hospital, Sheffield · Kai-ren Ong, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham · Lisa Walker, Churchill Hospital, Oxford · Lucy E. Side, Great Ormond Street Hospital for Children NHS Trust · Shirley Hodgson, St George's, University of London · Louise Izatt, Guy's and St Thomas' NHS Foundation Trust · Ros Eeles, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust · Nick Orr, The Institute of Cancer Research, London · Mary E. Porteous, Western General Hospital, Edinburgh · Rosemarie Davidson, South Glasgow University Hospitals, Glasgow · Julian Adlard, Chapel Allerton Hospital, Leeds, United Kingdom · Valentina Silvestri, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, and Laura Ottini, Sapienza University of Rome, Rome · Angela Toss, Veronica Medici, and Laura Cortesi, University of Modena and Reggio Emilia, Modena · Ines Zanna and Domenico Palli, Cancer Research and Prevention Institute, Florence · Paolo Radice, Siranoush Manoukian, Bernard Peissel, and Jacopo Azzollini, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT) · Paolo Peterlongo, Italian Foundation for Cancer Research Institute of Molecular Oncology (IFOM), Milan · Alessandra Viel and Giulia Cini, CRO Aviano, National Cancer Institute, Aviano · Giuseppe Damante, University of Udine, Udine · Stefania Tommasi, Istituto Nazionale Tumori "Giovanni Paolo II", Bari · Elisa Alducci, Silvia Tognazzo, and Marco Montagna, Veneto Institute of Oncology IOV - IRCCS, Padua · Maria A. Caligo, University and University Hospital of Pisa, Pisa, Italy · Penny Soucy and Jacques Simard, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec · Anna Marie Mulligan and Irene L. Andrulis, University of Toronto · Gord Glendon and Irene L. Andrulis, Mount Sinai Hospital, Toronto, Ontario, Canada · Melissa Southey, Ian Campbell, Paul James, and Gillian Mitchell, University of Melbourne, Parkville, Victoria · Amanda B. Spurdle, Helene Holland, and Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland · Ian Campbell, Paul James, and Gillian Mitchell, Peter MacCallum Cancer Centre, East Melbourne, New South Wales, Australia · Esther M. John, Cancer Prevention Institute of California, Fremont · Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, and Jeffrey N. Weitzel, City of Hope, Duarte, CA · Thomas A. Conner and Saundra S. Buys, Huntsman Cancer Institute · David E. Goldgar, University of Utah School of Medicine, Salt Lake City, UT · Andrew K. Godwin, University of Kansas Medical Center, Kansas City · Priyanka Sharma, University of Kansas Medical Center, Westwood, KS · Timothy R. Rebbeck, Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, Boston, MA · Joseph Vijai, Mark Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, and Kenneth Offit, Memorial Sloan Kettering Cancer Center, New York, NY · Jennifer T. Loud and Mark H. Greene, National Cancer Institute, Bethesda, MD · Amanda Ewart Toland and Leigha Senter, The Ohio State University, Columbus, OH · Dezheng Huo, Sarah M. Nielsen, and Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, IL · Katherine L. Nathanson and Susan M. Domchek, University of Pennsylvania, Philadelphia · Christa Lorenchick and Rachel C. Jankowitz, University of Pittsburgh Medical Center, Pittsburgh, PA · Fergus J. Couch, Mayo Clinic, Rochester, MN · Ramunas Janavicius, State Research Institute Innovative Medicine Center, Vilnius, Lithuania · Thomas V.O. Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen · Anders Bojesen and Henriette Roed Nielsen, Vejle Hospital, Vejle · Anne-Bine Skytte, Lone Sunde, and Uffe Birk Jensen, Aarhus University Hospital, Aarhus · Inge Sokilde Pedersen, Aalborg University Hospital, Aalborg · Lotte Krogh, Torben A. Kruse, and Mads Thomassen, Odense University Hospital, Odense, Denmark · Ana Osorio, National Cancer Research Centre and Spanish Network on Rare Diseases · Miguel de la Hoya, Vanesa Garcia-Barberan, Trinidad Caldes, and Pedro Perez Segura, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid · Judith Balmaña, University Hospital, Vall d'Hebron · Sara Gutiérrez-Enríquez and Orland Diez, Vall d'Hebron Institute of Oncology · Orland Diez, University Hospital Vall d'Hebron · Alex Teulé, Jesús Del Valle, Lidia Feliubadalo, Miquel Angel Pujana, and Conxi Lazaro, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona · Angel Izquierdo, Esther Darder, and Joan Brunet, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain · Florentia Fostira, National Centre for Scientific Research "Demokritos," Athens, Greece · Ute Hamann, German Cancer Research Center (DKFZ) · Christian Sutter, University Hospital Heidelberg, Heidelberg · Alfons Meindl, Klinikumrechts der Isar, Technical University Munich · Nina Ditsch, Ludwig-Maximilian University, Munich · Andrea Gehrig, University Würzburg, Würzburg · Bernd Dworniczak, University of Münster, Münster · Christoph Engel, University of Leipzig · Dorothea Wand, University Hospital, Leipzig · Dieter Niederacher, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf · Doris Steinemann, Hannover Medical School, Hannover · Eric Hahnen, Jan Hauke, Kerstin Rhiem, Barbara Wappenschmidt, and Rita K. Schmutzler, University Hospital Cologne, Cologne · Karin Kast, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden · Norbert Arnold, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel · Shan Wang-Gohrke, University Hospital Ulm, Ulm, Germany · Christine Lasset, Francesca Damiola, and Laure Barjhoux, Centre Léon Bérard · Sylvie Mazoyer, University of Lyon, Lyon · Dominique Stoppa-Lyonnet and Muriel Belotti, Institut Curie, Paris, France · Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, and Kathleen B.M. Claes, Ghent University, Gent, Belgium · Johanna I. Kiiski, Sofia Khan, and Heli Nevanlinna, University of Helsinki · Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, and Heli Nevanlinna, Helsinki University Hospital, Helsinki, Finland · Christi J. van Asperen, Leiden University Medical Center, Leiden, the Netherlands · Tibor Vaszko, Miklos Kasler, and Edith Olah, National Institute of Oncology, Budapest, Hungary · Adalgeir Arason, Bjarni A. Agnarsson, Oskar Th. Johannsson, and Rosa B. Barkardottir, Landspitali University Hospital and Biomedical Centre, University of Iceland, Reykjavik, Iceland · Manuel R. Teixeira and Pedro Pinto, Portuguese Oncology Institute · Manuel R. Teixeira, Porto University, Porto, Portugal · Jong Won Lee, Ulsan College of Medicine and Asan Medical Center · Min Hyuk Lee and Jihyoun Lee, Soonchunhyang University and Hospital · Sung-Won Kim and Eunyoung Kang, Daerim St Mary's Hospital · Sue Kyung Park, Seoul National University College of Medicine, Seoul · Zisun Kim, Soonchunhyang University Bucheon Hospital, Bucheon, Korea · Yen Y. Tan, Andreas Berger, and Christian F. Singer, Medical University of Vienna, Vienna, Austria · Sook-Yee Yoon and Soo-Hwang Teo, Sime Darby Medical Centre, Subang Jaya, Malaysia · and Anna von Wachenfeldt, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 28448241
  • Institut Curie, Supportive Care Department, Psycho-oncology Unit 26 rue d'Ulm, 75005 Paris Cedex 05, France; University Paris Descartes, 71, Avenue Edouard Vaillant, 92774 Boulogne-Billancourt, France. Electronic address: · Université de Lorraine, Inter-Psy, Inter-Psy, 3 Place Godefroy de Bouillon, BP 33 97, 54 015 Nancy Cedex, France. · Institut Curie, Cancer Genetic Clinic, 26 rue d'Ulm, 75005 Paris Cedex 05, France. · Gustave Roussy Hôpital Universitaire, Cancer Genetic Clinic, 114 rue Ed Vaillant, 94 805 Villejuif, France. · Hôpital Tenon Service d'Histologie-Biologie Tumorale, AP-HP, ER2 UPMC Université Pierre et Marie Curie, 4 rue de la Chine, 75020, France. · Institut Paoli-Calmettes, 232, Boulevard Sainte Margueritte, Marseille, France. · Institut Curie, Supportive Care Department, Psycho-oncology Unit 26 rue d'Ulm, 75005 Paris Cedex 05, France; CESP, Univ. Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France. · Pubmed 27837705
  • Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec, QC, G1V 4G2, Canada. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK. · The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus Hinxton, Cambridge, CB10 1HH, UK. · Department of Human Genetics, McGill University, Montreal, QC, H3A 1B1, Canada. · McGill University and Genome Quebec Innovation Centre, Montreal, QC, H3A 0G1, Canada. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, LS7 4SA, UK. · Department of Clinical Genetics, Helsinki University Hospital, HUS, Meilahdentie 2, P.O. BOX 160, 00029, Helsinki, Finland. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada. · Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Department of Pathology hus 9, Landspitali-LSH v/Hringbraut, 101, Reykjavík, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Vatnsmyrarvegi 16, 101, Reykjavík, Iceland. · Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Campus Kiel, 24105, Kiel, Germany. · Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University of Texas MD Anderson Cancer Center, 1515 Pressler Street CBP 5, Houston, TX, 77030, USA. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133, Milan, Italy. · Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, 711 Concession Street, Hamilton, ON, L8V 1C3, Canada. · Bâtiment Cheney D, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon, France. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), 28029, Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Centre François Baclesse, 3 avenue Général Harris, 14076, Caen, France. · Department of Clinical Genetics, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. · City of Hope Clinical Cancer Genomics Community Research Network, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon, France. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Via Ripamonti 435, 20141, Milan, Italy. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, EX1 2ED, UK. · Service de Génétique Oncologique, Institut Curie, 26 rue d'Ulm, 75248, Paris Cedex 05, France. · Department of Medicine, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. · Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy. · Unité de recherche en santé des populations, Centre des maladies du sein Deschênes-Fabia, Hôpital du Saint-Sacrement, 1050 chemin Sainte-Foy, Quebec, QC, G1S 4L8, Canada. · Departments of Pediatrics and Medicine, Columbia University, 1150 St. Nicholas Avenue, New York, NY, 10032, USA. · Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. · Division of Population Science, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, G51 4TF, UK. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Clinical and Molecular Genetics Area, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) National Cancer Institute, Via Franco Gallini 2, 33081, Aviano, PN, Italy. · University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, QLD, Australia. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Private Bag X323, Arcadia, 0007, South Africa. · Faculty of Medicine, University of Southampton, Southampton University Hospitals NHS Trust, Southampton, UK. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, SM2 5NG, UK. · Department of Oncology, Sahlgrenska University Hospital, 41345, Göteborg, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, 04107, Leipzig, Germany. · LIFE, Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, M13 9WL, UK. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, 199-203, L'Hospitalet, 08908, Barcelona, Spain. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic. · Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research "Demokritos", Patriarchou Gregoriou & Neapoleos str., Aghia Paraskevi Attikis, Athens, Greece. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, QC, Canada. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloníki, Greece. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, 52621, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, 69978, Ramat Aviv, Israel. · Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · UCLA Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, Room A2-125 HS, Los Angeles, CA, 90095-6900, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA. · Department of Clincial Genetics, Rigshospitalet, Blegdamsvej 9, 4062, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, 4019 Wahl Hall East, MS 3040, Kansas City, Kansas, USA. · Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM 4B454, Salt Lake City, UT, 84132, USA. · Clinical Genetics Branch, DCEG, NCI NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, USA. · Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, 70-115, Szczecin, Poland. · Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology (CIO), Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, 50931, Cologne, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. · Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, 43210, USA. · Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH, 43210, USA. · Comprehensive Cancer Center Arthur C. James Cancer Hospital and Richard J. Solove Research Institute Biomedical Research Tower, Room 588, 460 West 12th Avenue, Columbus, OH, 43210, USA. · Family Cancer Clinic, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Center for Medical Genetics, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, 1000 Central Street, Suite 620, Evanston, IL, 60201, USA. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia, 197758. · Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC, 20007, USA. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, SE1 9RT, UK. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, 3010, Australia. · Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Santariskiu st. 2, 08661, Vilnius, Lithuania. · State Research Institute Centre for Innovative Medicine, Zygymantu st. 9, Vilnius, Lithuania. · Department of Clinical Genetics, Aarhus University Hospital, Brendstrupgaardsvej 21C, Århus N, Denmark. · Department of Epidemiology, Cancer Prevention Institute of California, 2201 Walnut Avenue Suite 300, Fremont, CA, 94538, USA. · Department of Health Research and Policy (Epidemiology) and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Clinical Genetics Research Laboratory, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10044, USA. · Institute of Human Genetics, University of Ulm, 89091, Ulm, Germany. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, 90048, USA. · Department of Human Genetics, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. · Westmead Hospital, Familial Cancer Service, Hawkebury Road, P.O. Box 533, Wentworthville, NSW, 2145, Australia. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, P.O. Box 5201, 3008 AE, Rotterdam, The Netherlands. · Genetic Epidemiology of Cancer Team, INSERM U900, Institut Curie Mines ParisTech, PSL University, 26 rue d'Ulm, 75248, Paris Cedex 05, France. · Department of Oncology, Karolinska University Hospital, 17176, Stockholm, Sweden. · Department of Oncology, Lund University Hospital, 22185, Lund, Sweden. · Lyon Neuroscience Research Center-CRNL, INSERM U1028, CNRS UMR5292, University of Lyon, Lyon, France. · Department of Clinical Genetics, VU University Medical Center, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands. · NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Elm St & Carlton St, Buffalo, NY, 14263, USA. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Via Gattamelata 64, 35128, Padua, Italy. · Department of Laboratory Medicine and the Keenan Research Centre of the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, Haartmaninkatu 8, HUS, P.O. BOX 700, 00029, Helsinki, Finland. · Department of Medicine and Genetics, University of California, 513 Parnassus Ave., HSE 901E, San Francisco, CA, 94143-0794, USA. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 2115, Chicago, IL, USA. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK. · Department of Genetics, University Medical Center Groningen, University of Groningen, 9700 RB, Groningen, The Netherlands. · Unit of Medical Genetics, Department of Biomedical Experimental and Clinical Sciences, University of Florence, Viale Morgagni 50, 50134, Florence, Italy. · Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799, Korea. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Reberbansgade 15, Ålborg, Denmark. · Department of Oncology, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain. · IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, c/o IFOM-IEO Campus, Via Adamello 16, 20139, Milan, Italy. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, 33612, USA. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predicted Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), c/o Amaedeolab via GA Amadeo 42, 20133, Milan, Italy. · Department of Clinical Genetics, Karolinska University Hospital, L5:03, 171 76, Stockholm, Sweden. · Department of OB/GYN, Medical University of Vienna, Waehringer Guertel 18-20, A, 1090, Vienna, Austria. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, 7 Michal St., 34362, Haifa, Israel. · Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. · Clinical Genetics, Services Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. · Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, 2650 Ridge Avenue, Suite 1507, Walgreens, Evanston, IL, 60201, USA. · Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, 50931, Cologne, Germany. · Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany. · Oncogénétique, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France. · Medical Genetics Unit, St George's, University of London, London, SW17 0RE, UK. · Laboratoire de génétique médicale Nancy Université, Centre Hospitalier Régional et Universitaire, Rue du Morvan cedex 1, 54511, Vandoeuvre-les-Nancy, France. · Department of Pathology Region Zealand Section Slagelse, Slagelse Hospital, Ingemannsvej 18 Slagelse, Cpoenhagen, Denmark. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, 3010, Australia. · Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Herston Road, Brisbane, QLD, 4006, Australia. · Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Genetics, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Gran Via de l'Hospitalet, 199-203, L'Hospitalet, 08908, Barcelona, Spain. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS12/1A, 47500, Subang Jaya, Malaysia. · University Malaya Cancer Research Institute, University Malaya, 1 Jalan SS12/1A, 50603, Kuala Lumpur, Malaysia. · Department of Epidemiology, Columbia University, New York, NY, USA. · Department of Clinical Genetics, Odense University Hospital, Sonder Boulevard 29, Odense C, Denmark. · Latvian Biomedical Research and Study Centre, Ratsupites str 1, Riga, Latvia. · Department of Medical Genetics Level 6 Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Hills Road, Box 134, Cambridge, CB2 0QQ, UK. · Division of Human Genetics, Departments of Internal Medicine and Cancer Biology and Genetics Comprehensive Cancer Center, The Ohio State University, 998 Biomedical Research Tower, Columbus, OH, 43210, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, 330 Brookline Avenue, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, 3584 EA, Utrecht, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands. · Institute of Human Genetics, Charite Berlin, Campus Virchov Klinikum, 13353, Berlin, Germany. · Department of Human Genetics & Department of Clinical Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands. · Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, 0372, Oslo, Norway. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec, QC, G1V 4G2, Canada. · Pubmed 27796716
2016
  • Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Institut Bergonié, service de génétique - service de gynécologie, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut Curie, département de chirurgie, 75005 Paris, France. · Institut Curie, Saint-Cloud, service de génétique, 92210 Saint-Cloud, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Université Paris-Descartes, 75006 Paris, France. · Pubmed 26852151
  • Department Epidemiology, Dana Farber Cancer Institute and Harvard T.H. Chan School of Public Health, 1101 Dana Building, 450 Brookline Avenue, Boston, MA, USA. · Department Epidemiology, Dana Farber Cancer Institute and Harvard T.H. Chan School of Public Health, 1101 Dana Building, 450 Brookline Avenue, Boston, MA, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Biostatistics Unit, Group Health Research Institute, Seattle, WA, USA. · Department of Preventive Medicine, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, University of Southern California, California, USA. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada. · Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Molecular Diagnostics Laboratory, (INRASTES) Institute of Nuclear and Radiological Sciences and Technology, National Centre for Scientific Research "Demokritos", Patriarchou Gregoriou & Neapoleos str. Aghia Paraskevi Attikis, Athens, Greece. · Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University, Kiel, Germany. · Department of Breast Medical Oncology and Clinical Cancer Genetics Program, University Of Texas MD Anderson Cancer Center, 1515 Pressler Street, CBP 5, Houston, TX, USA. · Department of Genetics and Computational Biology, QIMR Berghofer Institute of Medical Research, Brisbane, Australia. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel. · Centre François Baclesse, 3 avenue Général Harris, Caen, France. · Department of Oncology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden. · Department of Medicine, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Martin Lagos s/n, Madrid, Spain. · Gynaecological Oncology, The University of Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. · Unité de recherche en santé des populations, Centre des maladies du sein Deschênes-Fabia, Hôpital du Saint-Sacrement, 1050, chemin Sainte-Foy, Québec, Canada. · Center for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Gent, Belgium. · Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota, USA. · Department of Genetics and Pathology, Pomeranian Medical University, Polabska 4, Szczecin, Poland. · Division of Population Science, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, Barcelona, Spain. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK. · Genomic Medicine, Manchester Academic Health Sciences Centre, Institute of Human Development, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 65653, Czech Republic. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, 69978, Israel. · UCLA Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research Jonsson Comprehensive Cancer Center, 650 Charles Young Drive South, Room A2-125 HS, Los Angeles, CA, 90095-6900, USA. · Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada. · Department of Pathology and Laboratory Medicine, 3901 Rainbow Boulevard, 4019 Wahl Hall East, MS, 3040, Kansas, USA. · University of Kansas Medical Center, Kansas City, Kansas, USA. · Clinical Genetics Branch, DCEG, NCI, NIH, 9609 Medical Center Drive, Room 6E-454, Bethesda, MD, USA. · Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany. · Department of Health Sciences Research, Mayo Clinic, 13400 E. Scottsdale Blvd., Scottsdale, AZ, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. · N.N. Petrov Institute of Oncology, St.-Petersburg, 197758, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road NW, Washington, DC, USA. · Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Santariskiu st, Vilnius, Lithuania. · State Research Institute Centre for Innovative medicine, Zygymantu st. 9, Vilnius, Lithuania. · Department of Epidemiology, Cancer Prevention Institute of California, 2201 Walnut Avenue, Suite 300, Fremont, CA, 94538, USA. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite 290W, Los Angeles, CA, USA. · Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia. · The Hong Kong Hereditary Breast Cancer Family Registry; Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong. · Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong. · Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, 28 rue Laënnec, Lyon, France. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute) Catalan Institute of Oncology, Gran Via de l'Hospitalet, 199-203, 08908, L'Hospitalet Barcelona, Barcelona, Spain. · Department of Oncology, Lund University Hospital, Lund, Sweden. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Via Giacomo Venezian 1, 20133, Milan, Italy. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Melbourne, VIC, 8006, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3052, Australia. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOC - IRCCS, Via Gattamelata 64, Padua, Italy. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki, P.O. BOX 700, (Haartmaninkatu 8), 00029, HUS, Helsinki, Finland. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · , 513 Parnassus Ave., HSE 901E, San Francisco, CA, 94143-0794, USA. · Clinical Genetics Research Laboratory, Department of Medicine, Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10044, USA. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · , 5841 South Maryland Avenue, MC 2115, Chicago, IL, USA. · Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 110-799, Korea. · NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Elm St & Carlton St, Buffalo, NY, 14263, USA. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predicted Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), c/o Amaedeolab, via GA Amadeo 42, 20133, Milan, Italy. · Department of OB/GYN, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria. · Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1000, BE, Amsterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic Erasmus University Medical Center Cancer institute, P.O. Box 5201, 3008, AE, Rotterdam, The Netherlands. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, 2705 Laurier Boulevard, Quebec City, Quebec, Canada. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, Paris, Cedex 05, France. · National Human Genome Research Institute, National Institutes of Health Building 50, Room 5312, 50 South Drive, MSC 004, Bethesda, MD, 20892-8004, USA. · Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy. · Department of Genetics, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS12/1A, Subang Jaya, 47500, Malaysia. · University Malaya Cancer Research Institute, University Malaya, 50603, Kuala Lumpur, Malaysia. · Department of Epidemiology, Columbia University, New York, NY, USA. · Department of Clinical Genetics, Odense University Hospital, Sonder Boulevard 29, Odense C, Denmark. · Latvian Biomedical Research and Study Centre, Ratsupites str 1, Riga, Latvia. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada. · Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, 998 Biomedical Research Tower, Columbus, OH, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Private Bag X323, Arcadia, 0007, South Africa. · Clinical Cancer Genetics Laboratory, Memorial Sloane Kettering Cancer Center, New York, NY, USA. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, California, 91010, USA. · Institute of Oncology, Rivka Ziv Medical Center, 13000, Zefat, Israel. · The Faculty of Medicine, Bar-Ilan University, Zefat, Israel. · , 4301 West Markham Street, Slot 793, Little Rock, AR, 72205, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Present Address: School of Women's and Children's Health, University of New South Wales and The Kinghorn Cancer Centre, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, NSW, 2010, Australia. · Pubmed 27836010
  • Aix Marseille Univ, INSERM, GMGF, Marseille, France. · APHM, Hôpital TIMONE Enfants, Laboratoire de Génétique Moléculaire, Marseille, France. · Laboratory Corporation of America, Westborough, Massachusetts. · Quest Diagnostics, Marlborough, Massachusetts. · Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France. · CHU et Institut Jean Godinot, Reims, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Institut Gustave Roussy, Villejuif, France. · CHU de Nancy-Brabois, Vandoeuvre-lés-Nancy, France. · Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Oncogénétique et Angiogénétique moléculaire, Université Pierre et Marie Curie, Paris, France. · CHU, Institut de Biologie, Hôtel Dieu, Nantes, France. · Université Paris Descartes, Paris, France. · CHU de Dijon, Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Paul Strauss, Strasbourg, France. · Quest Diagnostics, San Juan Capistrano, California. · Centre Oscar Lambret, Unité d'Oncologie Moléculaire Humaine, Lille, France. · Institut Bergonié, Bordeaux, France. · Hospices Civils de Lyon and Centre Léon Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. · Institut Claudius Régaud, Toulouse, France. · Laboratoire de biologie et de génétique du cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de Médecine Personnalisée, Caen, France. · Laboratoire de Biologie Cellulaire et Hormonale (CHU Arnaud de Villeneuve), Montpellier, France. · Laboratory Corporation of America, Research Triangle Park, North Carolina. · Pubmed 27633797
  • Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN, 37203-1738, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Proteomics Center, CHU de Québec Research Center and Department of Molecular Medicine, Laval University, Quebec, Canada. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Surgery, St Vincent's Hospital, Melbourne, VIC, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico), Padua, Italy. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Department of Pathology, Landspitali University Hospital and BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · McGill University and Génome Québec Innovation Centre, Montréal, Canada. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · International Epidemiology Institute, Rockville, MD, USA. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · International Agency for Research on Cancer, Lyon, France. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia. · Australian Breast Cancer Tissue Bank, Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea. · Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea. · Cancer Research Institute, Seoul National University, Seoul, South Korea. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Millenium Institute for Medical Research, University of Sydney, Sydney, Australia. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, Muenster, Germany. · Division of Population Sciences, Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · ANZ GOTG Coordinating Centre, Australia New Zealand GOG, Camperdown, NSW, Australia. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel. · Section of Genetic Oncology, Deparment of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Human Genetics, University Würzburg, Wurzburg, Germany. · INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Genetic Epidemiology of Cancer team, Inserm, U900, Institut Curie, Mines ParisTech, 75248, Paris, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. · University Paris-Sud, Villejuif, France. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. · Department of Surgery, National University Health System, Singapore, Singapore. · Cancer Research Initiatives Foundation, Subang Jaya, Selangor, Malaysia. · Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Suburban Hospital, Bethesda, MD, USA. · Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, N, Denmark. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Department of Pathology, Oulu University Hospital, University of Oulu, Oulu, Finland. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research "Demokritos", Athens, Greece. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Vesalius Research Center, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Surgery, Soonchunhyang University and Hospital, Seoul, South Korea. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Institute of Population Health, University of Manchester, Manchester, UK. · Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Beckman Research Institute of City of Hope, Duarte, CA, USA. · Carbone Cancer Center, University of Wisconsin, Madison, WI, USA. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, CA, USA. · Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · University Hospital Gashuisberg, Leuven, Belgium. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy. · Department of Obstetrics and Gynecology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel. · Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology (CIO), Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany. · Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, USA. · National Cancer Institute, Bangkok, Thailand. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany. · Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany. · School of Public Health, China Medical University, Taichung, Taiwan. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Hannover Medical School, Hannover, Germany. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · Department of Clinical Genetics, Odense University Hospital, Odense, C, Denmark. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, QC, Canada. · Currently at Medical School Cambridge University, Cambridge, UK. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland. · Singapore Eye Research Institute, National University of Singapore, Singapore, Singapore. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Peter MacCallum Cancer Center, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN, 37203-1738, USA. · Pubmed 27459855
  • Institut Curie, PSL Research University, Paris, France. · CNRS UMR 3244, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, Paris, France. · Institut Curie, PSL Research University, Department of Translational Research, the Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), Paris, France. · INSERM U981, Villejuif, France. · Univ Paris-Sud, UMR981, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Service de Génétique Oncologique, Institut Curie, Paris, France. · INSERM U830, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 27272900
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, 20133 Padua, Italy. · Department of Health Studies, The University of Chicago, Chicago, Illinois 60637, USA. · Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois 60637, USA. · Departments of Medicine and Human Genetics, The University of Chicago, Chicago, Illinois 60637, USA. · Department of Clinical Genetics, Helsinki University Central Hospital, 00029 Helsinki, Finland. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada M5B 1W8. · Department of Epidemiology, University of California Irvine, Irvine, California, 92697, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Oncology, Karolinska University Hospital, SE-17176 Stockholm, Sweden. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Department of Pathology, Landspitali University Hospital and University of Iceland School of Medicine, 101 Reykjavik, Iceland. · Institute for Quality and Efficiency in Health Care (IQWiG), 50670 Cologne, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain. · Genotyping Unit (CeGen), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), 28029 Madrid, Spain. · NYU Women's Cancer Program, New York University School of Medicine, New York, New York 10016, USA. · Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany. · University of Tübingen 72074 Tübingen, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City Utah 84112, USA. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid 28040, Spain. · Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, I-56126 Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Australian Breast Cancer Tissue Bank, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales 2145, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Departments of Pediatrics and Medicine, Columbia University, New York, New York 10032, USA. · Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium. · Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. · INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, 69373 Lyon, France. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands. · Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, 08035 Barcelona, Spain. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010, USA. · Cancer Bioimmunotherapy Unit, CRO Aviano National Cancer Institute, 33081 Aviano , Italy. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Pennsylvania 19104, USA. · Department of Genetics, University of Pretoria, Pretoria 0007, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada G1V 4G2. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, Hampshire SO16 6YD, UK. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala SE-751 85, Sweden. · Department of Clinical Genetics, Lund University Hospital, SE-22185 Lund, Sweden. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · Comprehensive Cancer Center -EMN, 91054 Erlangen, Germany. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Center for Primary Health Care Research, Lund University, SE-221 00 Malmö, Sweden. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, 15310 Athens, Greece. · Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada H3A 0G4. · University of, Philadelphia, Pennsylvania 19104, USA. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer 52621, Israel. · Department of Epidemiology, University of, Chapel Hill, North Carolina 27599-7400, USA. · UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095-6900, USA. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia 30303, USA. · Cancer Risk and Prevention Clinic, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California 90048, USA. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3010, Australia. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66205, USA. · Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1. · Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H4A 3J1. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850-9772, USA. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 70-115 Villejuif, France. · Department of of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, SW7 2AZ, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California 91010, USA. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam 1000 BE, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam 3008 AE, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam 3008 AE, The Netherlands. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · N.N. Petrov Institute of Oncology, 197758 St Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria 8006, Australia. · Department of Oncology, The University of Melbourne, Melbourne, Victoria 8006, Australia. · State Research Institute Centre for Innovative Medicine, LT-08661 Vilnius, Lithuania. · Department of Clinical Genetics, Aarhus University Hospital, 8200 Aarhus N, Denmark. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California 94538, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton SM2 5NG, UK. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, FI-70211 Kuopio, Finland. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Vesalius Research Center, VIB, 3000 Leuven, Belgium. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, 08908 Barcelona, Spain. · Department of Preventive Medicine, University of Southern California, Los Angeles, California 90032, USA. · Cancer Epidemiology Program, University of Cancer Center, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Health Sciences Research, Mayo Clinic, Scotsdale, Arizona 85259, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. · Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98195, USA. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), 20133 Milan, Italy. · Department of Gynaecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany. · NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Department of Genomics and Genome Sciences, Case Western Reserve University Medical School, Cleveland, Ohio 44106, USA. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada M5B 1W8. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada M5B 1W8. · Invitae Corporation, San Francisco, California 94107, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Department of Molecular Genetics, National Institute of Oncology, H-1122 Budapest, Hungary. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois 60637, USA. · Department of Preventive Medicine and Biomedical Science, Seoul National University College of Medicine and Cancer Research Institute, Seoul National University, 110-799 Seoul, Republic of Korea. · Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht 3508 GA, The Netherlands. · MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20133 Milan, Italy. · Divison of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, FI-90220 Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), 20133 Milan, Italy. · Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, UK. · Department of Clinical Genetics, Karolinska University Hospital, SE-17176 Stockholm, Sweden. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, A 1090 Vienna, Austria. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa 34362, Israel. · Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA. · International Agency for Research on Cancer, 69008 Lyon, France. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam 1006 BE, The Netherlands. · Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, 18014 Granada, Spain. · CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. · Department of Environmental Health Sciences, Columbia University, New York, New York, 10032, USA. · Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London SE1 9RT, UK. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne 50931, Germany. · Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, 50931 Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany. · Division of Genetics, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales 2305, Australia. · Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City, Kansas 66205, USA. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec City, Quebec, Canada G1V 4G2. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, 69373 Lyon, France. · Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia. · Hannover Medical School, 30625 Hannover, Germany. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, SE-58185 Linköping, Sweden. · Institut Curie, Department of Tumour Biology, 75248 Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, 75248 Paris, France. · National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-2152, USA. · Department of Genetics, Portuguese Oncology Institute, Porto, 4200-072, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, 4200-072 Porto, Portugal. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500, Malaysia. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur 50603, Malaysia. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, 10032, USA. · Department of Clinical Genetics, Odense University Hospital, 5000 Odense C, Denmark. · Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia. · Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, 43210, USA. · Department of Surgical Oncology, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, 08908 Barcelona, Spain. · Cancer Registry and Histopathology Unit, 'Civic-M.P. Arezzo' Hospital, 97100 ASP Ragusa, Italy. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, USA. · Cancer Registry of Norway, Institute of Population-Based Cancer Research, N-0304 Oslo, Norway. · Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam 3000 CA, The Netherlands. · Institute of Human Genetics, Charite Berlin, 13353 Berlin, Germany. · Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA. · University Hospital Ulm, 89075 Ulm, , Germany. · Department of Community Medicine, Faculty of Health Sciences, University of Tromsø-The Arctic University of Norway, 9037 Tromsø, Norway. · Genetic Epidemiology Group, Folkhälsan Research Center, 2016 Helsinki, Finland. · Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California 94305, USA. · Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals, B-3000 Leuven, Belgium. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Department of Biostatistics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850, USA. · Pubmed 27117709
  • Institut Curie, Paris, France. · CNRS UMR 3306, Orsay, France. · INSERM U1005, Orsay, France. · University Paris Sud 11, Orsay, France. · Department of Biostatistics and Medical Informatics, Assistance Publique-Hôpitaux de Paris, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, INSERM U975, CNRS UMR7225, UPMC Paris VI UMR S975, Paris, France. · Assistance Publique-Hôpitaux de Paris, Département de Génétique, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France. · University Paris Descartes, Sorbonne Paris Cité, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon, Centre Léon Bérard, Lyon, France. · Department of Tumour Biology, INSERM U830, Paris, France. · University of Grenoble Alpes, Grenoble Institut des Neurosciences, INSERM U1216, Grenoble, France. · INSERM, U1216, Grenoble, France. · Pubmed 26980106
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Breast Cancer Research, Breakthrough Breast Cancer Research Centre, London, UK. · Academic Biochemistry, Royal Marsden Hospital, London, UK. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Institute of Population Health, University of Manchester, Manchester, UK. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany. · Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, UK. · Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. · Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. · University Paris-Sud, Villejuif, France. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · Department of Epidemiology, University of California-Irvine, Irvine, California, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. · German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany. · Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany. · Centre of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology, University Hospital, Cologne, Germany. · Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan. · Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. · Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Vesalius Research Center, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Unit of Molecular Basis of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. · Department of Medicine, McGill University, Montreal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu University Hospital, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · International Epidemiology Institute, Rockville, Maryland, USA. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. · Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. · Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Department of Haematology-Oncology, National University Health System, Singapore. · Cancer Science Institute of Singapore, National University of Singapore, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore. · Department of Surgery, National University Health System, Singapore. · Institute of Human Genetics, Pontificia Universidad Javerianar, Bogota, Colombia. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · International Agency for Research on Cancer, Lyon, France. · National Cancer Institute, Bangkok, Thailand. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. · School of Public Health, China Medical University, Taichung, Taiwan. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, Institute of Cancer Research, London, UK. · Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, University La Sapienza, Rome, Italy. · Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. · Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, UK. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian Albrechts University Kiel, Kiel, Germany. · University Düsseldorf, Dusseldorf, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital of Cologne, Cologne, Germany. · Institute of Human Genetics, Münster, Germany. · INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong. · Department of Surgery, University of Hong Kong, Hong Kong. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Breast Cancer and Systems Biology Unit, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Medical Genetic Division, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada. · Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada. · Masaryk Memorial Cancer Institute and Medical Faculty, Masaryk University, Brno, Czech Republic. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA. · Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel. · Clalit National Israeli Cancer Control Center, Haifa, Israel. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Center for Medical Genetics, NorthShore University Health System, Evanston, Illinois, USA. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel. · Department of Oncology, Lund University, Lund, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California Los Angeles School of Medicine and School of Public Health, Los Angeles, California, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, California, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. · University of Hawaii Cancer Center, Honolulu, Hawaii, USA. · Department of Obstetrics, Gynaecology and Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada. · Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, Western Australia, Australia. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, USA. · Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Pubmed 26928228
  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Peter MacCallum Cancer Institute, East Melbourne, Australia. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · UPMC Cancer Center, Pittsburgh, PA, USA. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA. · Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, CA, USA. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark. · Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine, The Ohio State University, Columbus, OH, USA. · Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Center for Medical Genetics, North Shore University Health System, Evanston, IL, USA. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Oncology, Mayo Clinic, Rochester, MN, USA. · Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA. · Department of Surgery, Daerim St. Mary's Hospital, Seoul, Korea. · Department of Genetics, Portuguese Institute of Oncology, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Genetics, Portuguese Institute of Oncology, Porto, Portugal. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS (Scientific Institute of Hospitalization and Care), Padua, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS (Scientific Institute of Hospitalization and Care), Padua, Italy. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Oncology, Landspitali University Hospital and Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Genetic Counseling Unit, Hereditary Cancer Program, Biomedical Research Institute of Girona (IDIBGI), Catalan Institute of Oncology, Girona, Spain. · Breast Cancer and Systems Biology Unit, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, National Institute of Oncology, Budapest, Hungary. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Department of Oncology, San Carlos Clinical Hospital Health Research Institute (IdISSC), San Carlos Clinical Hospital, Madrid, Spain. · Molecular Oncology Laboratory, San Carlos Clinical Hospital Health Research Institute (IdISSC), San Carlos Clinical Hospital, Madrid, Spain. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Tumour Biology, Institut Curie, Paris, France. · CNRS UMR5558, Université Lyon 1, Lyon, France. · Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany. · Institute of Human Genetics, University of Wurzburg, Wurzburg, Germany. · Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics and Epidemiology University of Leipzig, Leipzig, Germany. · University of Dusseldorf, Dusseldorf, Germany. · Hannover Medical School, Hannover, Germany. · Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany. · Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany. · Department of Gynaecolgy and Obstetrics, University Hospital of Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany. · Institute of Human Genetics, Charité, Berlin, Germany. · Institute of Human Genetics, Leipzig, Germany. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Yorkshire Regional Genetics Service, Leeds, UK. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA. · Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology (INRASTES), National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Department of Medical Science, University of Turin, Turin, Italy. · AO Città della Salute e della Scienza, Turin, Italy. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Section of Medical Oncology, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy. · Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Scientific Institute of Hospitalization and Care), AOU San Martino - IST National Institute for Cancer Research, Genoa, Italy. · Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy. · Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy. · Unit of Genetic Counselling, Medical Oncology Department, Regina Elena National Cancer Institute, Rome, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), 20133, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Milan, Italy. · Division of Experimental Oncology, CRO Aviano National Cancer Institute, Aviano, PN, Italy. · IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · National Cancer Institute "Giovanni Paolo II", Bari, Italy. · IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Pubmed 26857456
  • Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines ParisTech, Fontainebleau, France. · Département de Médecine Oncologique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Institut Curie, Service de Génétique, Paris, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · CH Georges Renon, Service Oncogénétique pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Centre Eugène Marquis, Service de Génétique, Rennes, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · Inserm, U830, Université Paris-Descartes, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard, Lyon, France. · Pubmed 26785832
  • Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Institut Curie, Service de Génétique, Paris, France. · Institut de Cancérologie Gustave Roussy, Service d'Oncologie Génétique, Villejuif, France. · Institut Curie, Service de Génétique, Paris, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Institut Curie, Service de Génétique, Paris, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · Centre Eugène-Marquis, Service de Génétique, Rennes, France. · CH Georges Renon, Service Oncogénétique pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · ICL Alexis Vautrin, Unité d'Oncogénétique, Vandœuvre-lès-Nancy, France. · Centre François Baclesse, Unité de pathologie gynécologique, Caen, France. · Centre René Gauducheau, Unité d'Oncogénétique, Nantes Saint Herblain, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Hôpitaux Universitaires de Strasbourg, UF1422 Oncogénétique moléculaire, Laboratoire de diagnostic génétique, Strasbourg, France. · Hôpitaux Universitaires de Strasbourg, UF6948 Oncogénétique, Service d'Hémato-Oncologie, Strasbourg, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · Inserm, U896, CRCM Val d'Aurel, Montpellier, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Institut Bergonié, Bordeaux, France. · Centre Jean-Perrin, Clermont-Ferrand, France. · Centre Oscar-Lambret, Lille, France. · Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France. · Polyclinique Courlancy, Reims, France. · Clinique Sainte Catherine, Avignon, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Institut Claudius Regaud - IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Hôpital Bretonneau, Service de Génétique, Tours, France. · CHU Brest, Hôpital Morvan, Département de génétique médicale en pédiatrie, Brest, France. · Hôpital Tenon, Paris, France. · Hôpital Edouard Herriot, Service de Génétique Moléculaire, Lyon, France. · Hôpital Jeanne de Flandre, Service de génétique clinique Guy Fontaine, Lille, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Hôpital Pasteur, Service d'Onco-hématologie, Colmar, France. · CHRU Hôpital Caremeau, Nîmes, France. · Hôpital Tenon, Service d'Oncogénétique, Paris, France. · Institut Bergonié, Bordeaux, France. · IPC, Département d'Anticipation et de Suivi des Cancers, Marseille, France. · Inserm, UMR 912, Marseille, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, APHP, Paris, France. · Centre Hospitalier de Chambéry, Chambéry, France. · Institut Jean-Godinot, Reims, France. · ICC Courlancy, Cs Oncogénétique, Reims, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · CHU Hôpital Saint-Jacques, Service Génétique et Biologie du Développement - Histologie, Besançon, France. · Institut Bergonié, Bordeaux, France. · Hôpital Flaubert, Le Havre, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Hôpital Saint-Louis, Paris, France. · CHU de Saint-Etienne, Hôpital Nord, Service de Génétique, Saint-Etienne, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Hôpital Lariboisière, Centre Viggo-Petersen, Paris, France. · CHU Hôpital de Brabois, Laboratoire de Génétique, Vandœuvre-lès-Nancy, France. · CHU de Martinique, Unité d'Oncogénétique, Fort-de-France, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Institut Curie, Département d'imagerie médicale, Paris, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · PSL Research University, Paris, France. · Institut Curie, Service de Génétique, Paris, France. · Inserm, U830, Paris, France. · Université Paris-Descartes, Paris, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Pubmed 26758370
  • Centre De Recherche, Institut Curie, Paris, F-75248, France. · INSERM U830, Paris, F-75248, France. · Département De Biologie Des Tumeurs, Institut Curie, Paris, F-75248, France. · Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, K7L 3N6, Canada. · Centre De Ressources Biologiques, Institut Curie, Paris, F-75248, France. · Département De Recherche Translationnelle, Institut Curie, Paris, F-75248, France. · Sorbonne Paris Cité, University Paris-Descartes, Paris, F-75270, France. · Pubmed 26317927
  • Institut Curie, Département de Biopathologie, Paris, France. · Institut Curie, Inserm U830, Paris, France. · CHU Nantes, Service de Génétique médicale, Nantes, France. · Pôle Oncologie, Oncogénétique Poitou-Charentes, Niort, France. · CHU Angers, Service de Génétique médicale, Angers, France. · Université de Nantes, Faculté de Médecine de Nantes, Nantes, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Faculté des Sciences pharmaceutiques et biologiques, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Pubmed 26028024
  • Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France. · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Genetics, Institut Curie, Paris Descartes University, Paris, France. · Pubmed 26846839
2015
  • "Genetics of Breast Cancer" Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · Unité d'Oncologie Génétique, Centre Paul Strauss, Strasbourg, France. · "Genetics of Breast Cancer" Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines ParisTech, Fontainebleau, France. · Service d'Oncologie Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Service de Génétique, Institut Curie, Paris, France. · Unité d'Oncogénétique, ICL Alexis Vautrin, Vandœuvre-lès-Nancy, France. · Unité de Pathologie Gynécologique, Centre François Baclesse, Caen, France. · Service Oncologie Médicale, Centre René Gauducheau, Nantes Saint Herblain, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Unité de Prévention et Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Service d'Oncologie, UF6948, Hôpital Civil, Strasbourg, France. · Service de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France. · INSERM U896, CRCM Val d'Aurel, Montpellier, France. · Institut Bergonié, Bordeaux, France. · Centre Jean-Perrin, Clermont-Ferrand, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France. · Inserm, U830, Paris, France. · Université Paris-Descartes, Paris, France. · Unité d'Oncologie Génétique, Centre Paul Strauss, Strasbourg, France. · Pubmed 26564480
  • Department of Medical Oncology, Institut Curie, 75248 Paris, France. · Department of Medical Oncology, University Hospital, 25000 Besançon, France. · Medical Department, University of Franche-Comté, 25000 Besançon, France. · Medical Oncology Department, INSERM U1098, 25000 Besançon, France. · Present affiliations: 2-4; affiliation when working on this case: 1. · Université Paris Sciences Lettres, Medical Department, INSERM U934, Institut Curie, 75248 Paris, France. · Université Paris Sciences Lettres, Medical Department, INSERM U830, Institut Curie, 75248 Paris, France. · Department of Translational Research, Institut Curie, 75248 Paris, France. · Department of Pathology, Genetics and Immunology, Institut Curie, 75248 Paris, France. · Pubmed 26426992
  • Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. · Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. · Centre de Recherche en Cancérologie de Lyon, UMR Inserm, Centre Léon Bérard, Lyon, France. · Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia6Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. · Sheba Medical Center, Tel Aviv, Israel. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Israel. · Oncology Institute, Sheba Medical Center, Tel Hashomer, Israel. · Oncology Institute, Rivkah Ziv Medical Center Zefat, Israel. · Department of Oncology, Lund University, Lund, Sweden12Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Oncology, Lund University, Lund, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois. · UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California. · Department of Medicine and Genetics, University of California, San Francisco. · Cancer Risk Program, Helen Diller Family Cancer Center, University of California, San Francisco. · Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. · University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia 25Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Epidemiology, Columbia University, New York, New York. · Departments of Pediatrics and Medicine, Columbia University, New York, New York. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Institute Innovative Medicine Center, Vilnius, Lithuania. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California. · Departments of Oncology or Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Hospital clinico Universitario "Lozano Blesa," Instituto de investigación sanitaria de Aragón (IIS), Zaragoza, Spain. · Molecular Genetics Laboratory (Department of Genetics), Cruces University Hospital Barakaldo, Bizkaia, Spain. · Institute of Biology and Molecular Genetics. Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California. · Unit of Genetic Counselling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · Department of Medical Science, University of Turin, and AO Città della Salute e della Scienza, Turin, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · AO Città della Salute e della Scienza, Turin, Italy. · Department of Molecular Medicine, University La Sapienza, Rome, Italy. · Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy57Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Institute of Medical Genetics, Catholic University, "A. Gemelli" Hospital, Rome, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy60IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Cancer Bioimmunotherapy Unit, Centro di Riferimento Oncologico, IRCCSCRO Aviano National Cancer Institute, Aviano (PN), Italy. · Cogentech Cancer Genetic Test Laboratory, Milan, Italy60IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Unit of Hereditary Cancer, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research "Demokritos" Aghia Paraskevi Attikis, Athens, Greece. · Instituto de Genética Humana, Pontificia Universidad Javeriana, Bogotá, Colombia65Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. · Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany 66Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan. · Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, United Kingdom. · Oncogenetics Team, Institute of Cancer Research and Royal Marsden, NHS Foundation Trust, London, United Kingdom. · Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom. · Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, United Kingdom. · Clinical Genetics Department, St Georges Hospital, University of London, United Kingdom. · Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire. · South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · South West Regional Genetics Service, Bristol, United Kingdom. · Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City. · Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany. · Institute of Human Genetics, University of Regensburg, Regensburg, Germany. · Institut Curie, Department of Tumour Biology, Paris, France98Institut Curie, INSERM U830, Paris, France99Université Paris Descartes, Sorbonne Paris Cité, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France101INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France99Université Paris Descartes, Sorbonne Paris Cité, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Université Lyon 1, CNRS UMR5558, Lyon, France103Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Département Oncologie Génétique, Prévention et Dépistage, INSERM CIC-P9502, Institut Paoli-Calmettes/Université d'Aix-Marseille II, Marseille, France. · Laboratoire d'Oncologie Moléculaire Humaine, Centre Oscar Lambret, Lille, France. · Unité d'Oncogénétique, CLCC Paul Strauss, Strasbourg, France. · Service de Génétique Biologique-Histologie-Biologie du Développement et de la Reproduction, Centre Hospitalier Universitaire de Besançon, Besançon, France. · Service de Génétique, Centre Hospitalier Universitaire Bretonneau, Tours, France. · Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Laboratoire d'Oncogénétique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · GOG Statistical and Data Center, Buffalo, New York. · Evanston Hospital, Evanston, Illinois. · Tufts University, Medford, Massachusetts. · University of North Carolina, Chapel Hill. · New York University, New York, New York. · Ohio State, Good Samaritan Hospital, Cincinnati. · Yale University School of Medicine, New Haven, Connecticut. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Genetics, University Medical Center, Groningen University, Groningen, The Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · Department of Human Genetics and Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong135Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong136Department of Surgery, University of Hong Kong, Hong Kong. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autonoma de Barcelona, Barcelona, Spain139University Hospital of Vall d'Hebron, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland144Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology, Landspitali University Hospital, Reykjavík, Iceland147BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center, Quebec City, Quebec, Canada149Laval University, Quebec City, Quebec, Canada. · Medical Genetics Division, Centre Hospitalier Universitaire de Québec, Quebec City, Quebec, Canada151Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal153Biomedical Sciences Institute (ICBAS), University of Porto, Portugal. · Department of Surgery, Soonchunhyang University and Hospital, Seoul, Korea. · Department of Preventive Medicine, Seoul National University College of Medicine and Cancer Research Institute, Seoul National University, Seoul, Korea. · Department of Surgery, Daerim St Mary's Hospital, Seoul, Korea. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota159Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada161Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and MF MU, Brno, Czech Republic. · Clinical Genetics Service, Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland. · N. N. Petrov Institute of Oncology, St Petersburg, Russia. · Divison of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus. · Divison of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, Ohio State University, Columbus. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Section of Genetic Oncology, Department of Oncology, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia176Department of Surgery, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Kuala Lumpur, Malaysia. · NorthShore University HealthSystem, Department of Medicine, Evanston, Illinois. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada. · Pubmed 25849179
  • CERMES3, 7, rue Guy Môquet, 94801 Villejuif, France. · Institut Curie, Université Paris Descartes, 26, rue d'Ulm, 75248 Paris, France. · Pubmed 25744269
2012
  • The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK. · Signal Transduction Laboratory, Cancer Research UK London Research Institute, WC2A 3LY, UK. · Institut Curie, INSERM U830, 75248 Paris, France. · Breakthrough Research Unit, Bermondsey Wing, Guy's Hospital, London, SE1 9RT, UK. · CRUK Clinical Trials Unit, The Institute of Cancer Research, Sutton, SM2 5NG, UK. · University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands. · Institut Curie, Department of Tumour Biology, 75248 Paris, France. · Signal Transduction Team, Division of Cell and Molecular Biology, The Institute of Cancer Research, London, SW3 6JB, UK. · Centre for Cancer Research and Cell Biology, Queen's University, Belfast, BT9 7BL, Northern Ireland, UK. · Nuclear Receptor Transcription Laboratory, Cancer Research UK Cambridge Research Institute, Cambridge, CB2 0RE, UK. · Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals Trust, Nottingham, NG7 2UH, UK. · Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute, WC2A 3LY, UK. · UCL Cancer Institute, Huntley Street, London WC1E 6DD, UK. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, QC, H2W 1S6, Canada. · Pubmed 22362584
2017
  • Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy. · Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California, Irvine, Irvine, California, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. · Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Institute of Human Genetics, Hannover Medical School, Hannover, Germany. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy. · McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada. · Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Bâtiment Cheney D, Centre Léon Bérard, Lyon, France. · Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Spanish Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · International Epidemiology Institute, Rockville, Maryland, USA. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Gustave Roussy, Biopathology Department, Villejuif, France. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain. · Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) and Centro Nacional de Genotipado (CEGEN-PRB2), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain. · Centre François Baclesse, Caen, France. · Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University of Münster, Münster, Germany. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genetics Department, Dijon University Hospital, Dijon, France. · Oncogenetics, Centre Georges-François Leclerc, Dijon, France. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada. · Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Medicine, McGill University, Montréal, Québec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada. · Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Pubmed 29058716
2016
  • Leuven Cancer Institute, KU, Leuven, European Union, Belgium. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Copenhagen University Hospital, Denmark. · Department of Clinical Genetics, Leiden University Medical Center, Netherlands. · Innsbruck Medical University, Austria. · Portuguese Institute of Oncology, Lisbon, Portugal. · Department of Medical Oncology, CRLCC Léon Bérard, University Claude Bernard Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France; Charité University of Medicine Berlin, Germany; University of Milan-Bicocca, and European Institute of Oncology, Italy. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, France. · MD Anderson Cancer Center Madrid, Spain. · Pubmed 27821315
  • Department of Tumour Biology, Institut Curie, Paris, France. · INSERM U830, Institut Curie, Paris, France. · Department de Génétique, Université Paris Descartes, Service de Génétique, Institut Curie, Paris, France. · Pubmed 27514841
2015
  • INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Centre Catherine de Sienne, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Département de Cancérologie sénologique, CLCC Oscar Lambret, Lille, France. · Centre François Baclesse, Caen, France. · Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Université Lyon 1, CNRS UMR5558, Lyon, France; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France. · Université Lyon 1, INCa-Synergie, Centre Léon Bérard, 28 rue Laennec, Lyon Cedex 08, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · Pubmed 26406445
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. · Genome Instability and DNA Repair Group, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona and Center for Biomedical Network Research on Rare Diseases (CIBERER), Barcelona, Spain. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Department of Experimental Oncology and Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. · Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany, Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · INSERM, U900, Paris, France, Institut Curie, Paris, France, Mines ParisTech, Fontainebleau, France. · Service de Génétique Oncologique, Institut Curie, Paris, France, INSERM, U830, Paris, France, Université Paris-Descartes, Paris, France. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France, Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France. · Familial Cancer Centre, Sir Peter MacCallum Department of Oncology and. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and. · Department of Immunohematology and Transfusion Medicine and. · Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy, Institute of Medical Genetics, 'A. Gemelli' School of Medicine, Catholic University, Rome, Italy. · Dipartimento di Oncologia, Ematologia e Malattie dell'Apparato Respiratorio, Università di Modena e Reggio Emilia, Modena, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Cancer Bio-Immunotherapy Unit and. · Unit of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Unit of Hereditary Cancers, IRCCS AOU San Martino - IST, Genoa, Italy. · Medical Genetics, University of Siena, Siena, Italy, Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · SC Medical Genetics, ASl8 Cagliari, Cagliari, Italy. · Unit of Pathology, Ospedale di Circolo, Varese, Italy. · Section of Genetic Oncology, University Hospital and University of Pisa, Pisa, Italy. · IRCCS Istituto Tumori 'Giovanni Paolo II', Molecular Genetics Laboratory, Bari, Italy. · Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain, Spanish Genotyping Centre (CEGEN), Madrid, Spain. · Scientific Directorate and. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics, Department of Pathology and. · Department of Human Genetics. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Oncogenetics Group, Hospital Universitari de la Vall d'Hebron, Barcelona, Spain, Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain. · Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Department of Medical Oncology, Hospital Universitari de la Vall d́Hebron, Barcelona, Spain. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy. · Catalan Institute of Oncology - IDIBELL, Barcelona, Spain. · Clinical Genetics Service, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Oncology, Department of Clinical Sciences. · Department of Clinical Genetics, Laboratory Medicine, Office for Medical Services and Department of Clinical Genetics, Lund University, Lund, Sweden. · Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 26130695
  • INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Université de Lyon, 69000, Lyon, France. · Université Lyon 1, 69100, Villeurbanne, France. · Université de Lyon, 69000, Lyon, France. · Université Lyon 1, 69100, Villeurbanne, France. · UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), "Biométrie et Biologie Évolutive", Université Claude Bernard Lyon 1, Bâtiment Grégor Mendel, 43 boulevard du 11 novembre 1918, 69622, Villeurbanne, cedex, France. · Université Grenoble Alpes, UMR 5217, Laboratoire d'Informatique de Grenoble (LIG), équipe-projet Multi-programmation et Ordonnancement sur ressources pour les Applications Interactives de Simulation (MOAIS), 38041, Grenoble, France. · INRIA Rhône-Alpes, équipe-projet MOAIS, 38334, Saint Ismier, Cedex, France. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre de recherche du Centre hospitalier universitaire de Québec, Laval University, Charlesbourg, PQ, Canada. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania. · Department of Molecular and Regenerative Medicine, Centre for Innovative Medicine, State Research Institute, Vilnius, Lithuania. · Latvian Biomedical Research and Study Centre, Rātsupītes iela 1, Rīga, LV-1067, Latvia. · Division of Hematology Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Shapiro 9, Boston, MA, 02215-5400, USA. · Department of Genetics, University of Pretoria, Private Bag X20, Hatfield, 0028, Pretoria, South Africa. · Department of Genetics, University of Pretoria, Private Bag X20, Hatfield, 0028, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Department of Population Sciences, Beckman Research Institute, City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain. · Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain. · Medical Oncology Service, Hospital Clínico Universitario Lozano Blesa, Avenida San Juan Bosco, 15, 50009, Zaragoza, Spain. · Holy Cross Hospital, Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, FL, USA. · Clinical Cancer Genetics Community Research Network, City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Division of Clinical Cancer Genetics, City of Hope (for the Clinical Cancer Genetics Community Research Network), City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · John Muir Medical Center, Walnut Creek, CA, USA; c/o Clinical Cancer Genetics Community Research Network, City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Istituto FIRC di Oncologia Molecolare (IFOM), Via Adamello 16, 20139, Milan, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori (INT), Via Venezian 1, 20133, Milan, Italy. · Division of Clinical Cancer Genetics, City of Hope (for the Clinical Cancer Genetics Community Research Network), City of Hope, 1500 East Duarte Road, Duarte, CA, 91010, USA. · Cogentech Cancer Genetic Test Laboratory, Via Adamello 16, 20139, Milan, Italy. · Cancer Bioimmunotherapy Unit, Centro di Riferimento Oncologico (CRO), Via Franco Gallini 2, 33081, Aviano, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori (INT), Via Venezian 1, 20133, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori (INT), Via Venezian 1, 20133, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori (INT), Via Venezian 1, 20133, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori (INT), Via Venezian 1, 20133, Milan, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Azienda Ospedaliera Universitaria "San Martino" di Genova, IST Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, 10, 16132, Genoa, Italy. · FiorGen Foundation for Pharmacogenomics, Via Luigi Sacconi 6, 50019, Sesto Fiorentino, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, Sapienza University, Rome, Italy. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany. · Clinical Genetics Department, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, UK. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK. · Merseyside and Cheshire Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Crown Street, Liverpool, Merseyside, L8 7SS, UK. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, CB1 8RN, UK. · Faculty of Medicine, University of Southampton, Southampton University Hospitals NHS Trust, Mailpoint 801, South Academic Block, PAH/G/MP105, Tremona Road, Southampton, SO16 6YD, UK. · Institute of Human Genetics, Northern Genetic Service, International Centre for Life, Newcastle upon Tyne Hospitals NHS Trust, Central Parkway, Newcastle upon Tyne, NE1 4EP, UK. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Old Medical School, Leeds General Infirmary, Leeds, LS1 3EX, UK. · Leicestershire Clinical Genetics Service, Department of Clinical Genetics, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, UK. · Oxford Regional Genetics Service, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LE, UK. · Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, 7th floor, Borough Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, Barclay House, 37, Queen Square, London, WC1N 3BH, UK. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, Barclay House, 37, Queen Square, London, WC1N 3BH, UK. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin, College Green, Dublin 2, Ireland. · Medical Oncology Service, St James's Hospital, James's Street, Dublin 8, Ireland. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrooke's Hospital, Level 6, Addenbrooke's Treatment Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. · All Wales Medical Genetics Services, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK. · South East Scotland Regional Genetic Service, Western General Hospital, David Brock Building, Crewe Road South, Edinburgh, EH4 2XU, UK. · Centre for Cancer Research & Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7AE, UK. · Department of Medical Genetics, Belfast Health and Social Care Trust, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, CB1 8RN, UK. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 123 Old Brompton Road, London, SW7 3RP, UK. · Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Block 4, Glasgow, G3 8SJ, UK. · South West Thames Regional Genetics Service, Department of Medical Genetics, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2TG, UK. · Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. · Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC, 20057, USA. · Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. · Division of Tumor Genetics, Department of Gynaecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. · Center of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institut für Humangenetik, Biozentrum, Universität Würzburg, Am Hubland, 97074, Würzburg, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, Center for Integrated Oncology (CIO) Cancer Center Cologne, University Hospital Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Strasse 21, 50931, Cologne, Germany. · Department of Human Genetics, Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, Medical Faculty, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Moorenstrasse 5, 40225, Düsseldorf, Germany. · Institute of Cell and Molecular Pathology, Centre for Pathology and Forensic and Genetic Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. · Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, D-24105, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus of Dresden, Technical University Dresden, Dresden, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, Center for Integrated Oncology (CIO) Cancer Center Cologne, University Hospital Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Strasse 21, 50931, Cologne, Germany. · Division of Tumor Genetics, Department of Gynaecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. · Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, D-24105, Kiel, Germany. · Institute of Medical Genetics and Human Genetics, Campus Virchow-Klinikum, Charité Berlin - Universtitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, Center for Integrated Oncology (CIO) Cancer Center Cologne, University Hospital Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Strasse 21, 50931, Cologne, Germany. · German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC), Cologne, Germany. · Institute of Human Genetics, University Hospital Münster, Vesaliusweg 12-14, 48149, Münster, Germany. · Institute of Human Genetics, University Hospital Münster, Vesaliusweg 12-14, 48149, Münster, Germany. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Department of Tumour Biology, Institut Curie, 26 rue d'Ulm 75248, Paris, cedex 05, France. · Department of Tumour Biology, Institut Curie, 26 rue d'Ulm 75248, Paris, cedex 05, France. · UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), "Biométrie et Biologie Évolutive", Université Claude Bernard Lyon 1, Bâtiment Grégor Mendel, 43 boulevard du 11 novembre 1918, 69622, Villeurbanne, cedex, France. · Unité de Prévention et d'Épidémiologie Génétique, Centre Léon Bérard, 28 rue Laenned, 69008, Lyon, France. · Génétique Clinique, Centre Hospitalier Universitaire de Grenoble, CS 10217, 38043, Grenoble, cedex 9, France. · Institut Albert Bonniot - Inserm U823, Université Joseph Fourier, Rond-point de la Chantourne, 38706, La Tronche, France. · Laboratoire d'Oncogénétique, Hôpital René Huguenin, Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Génétique Clinique, Centre Hospitalier Universitaire de Grenoble, CS 10217, 38043, Grenoble, cedex 9, France. · Institut Albert Bonniot - Inserm U823, Université Joseph Fourier, Rond-point de la Chantourne, 38706, La Tronche, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, 26 rue d'Ulm 75248, Paris, cedex 05, France. · Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, 58 rue Montalembert, BP 392, 63011, Clermont-Ferrand, France. · UMR CNRS 5558, Laboratoire de Biométrie et Biologie Évolutive (LBBE), "Biométrie et Biologie Évolutive", Université Claude Bernard Lyon 1, Bâtiment Grégor Mendel, 43 boulevard du 11 novembre 1918, 69622, Villeurbanne, cedex, France. · Unité de Prévention et d'Épidémiologie Génétique, Centre Léon Bérard, 28 rue Laenned, 69008, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, 58 rue Montalembert, BP 392, 63011, Clermont-Ferrand, France. · Gynaecological Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital and University of Sydney, Missenden Road, Camperdown, NSW, 2050, Australia. · Gynecologic Oncology Group, Department of OB-GYN, University of North Carolina at Chapel Hill, 103B Physicians' Office Building, CB# 7572, Chapel Hill, NC, 27599-7572, USA. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY, 14263-0001, USA. · Women & Infants Hospital, 1 Blackstone Place, Providence, RI, 02905, USA. · Molecular Oncology Laboratory, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040, Madrid, Spain. · Molecular Oncology Laboratory, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), 28040, Madrid, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Biomedicum Helsinki, PO Box 700, 00029, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Biomedicum Helsinki 1, Haartmaninkatu 8, 00290, Helsinki, Finland. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, PO Box 2040, 3000, CA, Rotterdam, the Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Center Amsterdam, De Boelelaan 1118, 1081 HV, Amsterdam, the Netherlands. · Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Human Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, S4-P PO Box 9600, 2300, RC, Leiden, the Netherlands. · Department of Pathology, Leiden University Medical Center, PO Box 9600, 2300 RC L1Q, Leiden, the Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Ráth György u 7-9, PO Box 1525 Budapest PF 21, 1122, Budapest, Hungary. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron 119, 08035, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Catalan Institute of Oncology, Hospital Duran i Reynals, 3a planta - Gran Via de l'Hospitalet, 199, 08908, Hospitalet de Llobregat, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Catalan Institute of Oncology, Hospital Duran i Reynals, 3a planta - Gran Via de l'Hospitalet, 199, 08908, Hospitalet de Llobregat, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Catalan Institute of Oncology, Hospital Duran i Reynals, 3a planta - Gran Via de l'Hospitalet, 199, 08908, Hospitalet de Llobregat, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)-Catalan Institute of Oncology, Hospital Duran i Reynals, 3a planta - Gran Via de l'Hospitalet, 199, 08908, Hospitalet de Llobregat, Barcelona, Spain. · Department of Genetics and Pathomorphology, Faculty of Medicine and Dentistry, Pomeranian Medical University, al Powstancow Wlkp 72, 70-111, Szczecin, Poland. · Department of Genetics and Pathomorphology, Faculty of Medicine and Dentistry, Pomeranian Medical University, al Powstancow Wlkp 72, 70-111, Szczecin, Poland. · Department of Genetics and Pathomorphology, Faculty of Medicine and Dentistry, Pomeranian Medical University, al Powstancow Wlkp 72, 70-111, Szczecin, Poland. · Department of Genetics and Pathomorphology, Faculty of Medicine and Dentistry, Pomeranian Medical University, al Powstancow Wlkp 72, 70-111, Szczecin, Poland. · Department of Genetics and Pathomorphology, Faculty of Medicine and Dentistry, Pomeranian Medical University, al Powstancow Wlkp 72, 70-111, Szczecin, Poland. · Pubmed 25925750
  • Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America. · Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh. · Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America. · Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain. · All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom. · All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom. · Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands. · Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America. · Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America. · Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America. · Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy. · Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy. · Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece. · Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Women's College Research Institute, University of Toronto, Toronto, Canada. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel. · The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · N.N. Petrov Institute of Oncology, St.-Petersburg, Russia. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America. · The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France. · Centre François Baclesse, Caen, France. · Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France. · Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Pubmed 25830658
  • Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. Inserm, U830, Paris, France. Université Paris-Descartes, Paris, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. CNRS UMR 5558, Lyon, France. Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Centre François Baclesse, Unité de pathologie gynécologique, Caen, France. · Institut de Cancérologie Gustave Roussy, Service d'Oncologie Génétique, Villejuif, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. Hôpital d'enfants, Service de Génétique Médicale, Dijon, France. · CH Georges Renon, Pôle Oncologie pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · IPC, Département d'Anticipation et de Suivi des Cancers, Marseille, France. INSERM, UMR 912, Marseille, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Institut Claudius Regaud-IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · ICL Alexis Vautrin, Unité d'Oncogénétique, Vandœuvre-lès-Nancy, France. · Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France. · Nouvel Hôpital Civil, Laboratoire de Diagnostic Génétique, Strasbourg, France. · Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, APHP, Paris, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Pubmed 25613119
  • IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany, on behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC). · Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, United Kingdom. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia. · Department of Pathology, University of Otago, Christchurch, New Zealand. · Department of Biomedical Sciences and Medicine, Gambelas Campus, University of Algarve, Portugal. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Clinical Genetics, MUMC, Maastricht, the Netherlands. · Center for Clinical Cancer Genetics, Department of Medicine and Human Genetics, University of Chicago Medical Center, Chicago, Illinois. · Department of Medicine and Institute for Human Genetics, University of California, San Francisco, San Francisco, California. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Departments of Pediatrics and Medicine, Columbia University, New York, New York. · Department of Genetics and Genomics at Case Western Reserve Medical School, Cleveland, Ohio. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Dept. of Molecular and Regenerative Medicine; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Molecular Genetics Laboratory, Department of Biochemistry, Cruces Hospital Barakaldo, 48903-Barakaldo-Bizkaia, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Saint Alphonsus Regional Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California (for the City of Hope Clinical Cancer Genetics Community Research Network). · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Department of Molecular Medicine, Sapienza University, Rome, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental, and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Genetic Counseling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · UO Anatomia Patologica Ospedale di Circolo e Fondazione Macchi, Polo Universitario Varese, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Dana-Farber Cancer Institute, Boston, Massachuestts. · Clinical Genetics Department, St. Michael's Hospital, Bristol, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · University of Southampton, Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin, Ireland. St. James's Hospital, Dublin, Ireland. · All Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · Centre for Cancer Research and Cell Biology, Queens University of Belfast, Department of Medical Genetics, Belfast HSC Trust, Belfast, United Kingdom. · West of Scotland Regional Genetics Service, Southern General Hospital, Glasgow, United Kingdom. · Medical Genetics Unit, St. George's, University of London, London, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Missouri. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Germany. · Institute of Human Genetics, University Würzburg, Wurzburg, Germany. · University Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany. · University Düsseldorf, Dusseldorf, Germany. · Hannover Medical School, Hanover, Germany. · Institute of Human Genetics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany. · Department of Gynaecology and Obstetrics, University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Institute of Human Genetics, Charite Berlin, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany. · INSERM U946, Fondation Jean Dausset, Paris, France. Service de Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Centre René Gauducheau, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. Institut Curie, INSERM U830, Paris, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Department of Medical Oncology, Centre Hospitalier Universitaire Dupuytren, Limoges, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York. · Australia New Zealand Gynaecological Oncology Group (ANZGOG), Coordinating Centre, Camperdown, Australia. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois. · Ohio State University, Department of Obstetrics and Gynecology, Hilliard, Ohio. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands. · Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands. · Department of Human Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands. · Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Erasmus University MC Cancer Institute, Rotterdam, the Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Group, University Hospital Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Centre de Recherche FRSQ du Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Health Sciences Research, Mayo Clinic, Scottsdale, Arizona. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnessotta. · National Human Genome Research Institute, NIH, Bethesda, Maryland. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Diagnostic Molecular Genetics Laboratory, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland. · Clalit National Cancer Control Center, Haifa, Israel. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Sheba Medical Center, Tel Aviv, Israel. · Pubmed 25336561
2014
  • Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece. · Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain. · Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America. · Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America. · Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy. · Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom. · South West Regional Genetics Service, Bristol, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Prince of Wales Hospital. Sydney, Australia. · Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America. · For Tufts Medical Center, Boston, Massachusetts, United States of America. · Yale University School of Medicine, New Haven, Connecticut, United States of America. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands. · Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland. · Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia. · Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America. · Clalit National Israeli Cancer Control Center, Haifa, Israel. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · Pubmed 24698998
  • 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France. · INSERM U900, Mines Paris Tech, Centre de Recherche de l'Institut Curie, Paris, France. · Service de Génétique Oncologique, Institut Curie, Paris, France. · Next Generation Sequencing Platform, Centre de Recherche de l'Institut Curie, Paris, France. · 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Pubmed 23942203
2013
  • Institut Curie, Department of Tumour Biology, 26 rue d'Ulm, 75248, Paris, Cedex 05, France. · Pubmed 24139550
  • Institut Curie, Centre de Recherche, Paris, France; INSERM U830, Paris, France; Department of Tumor Biology, Institut Curie, Paris, France. · Pubmed 23754601
2012
  • Department of Tumor Biology, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. · Pubmed 22711610
  • Institut Curie, unité de psycho-oncologie, département interdisciplinaire de soins de support pour le patient en oncologie, 26, rue d'Ulm, 75248 Paris, France. · Pubmed 22641341
2011
  • Institut Curie, unité de psycho-oncologie, département interdisciplinaire de soins de support pour le patient en oncologie, Paris, France. · Pubmed 21382771
  • Institut Curie, Centre de Recherche, 26 rue d'Ulm, Paris, France. · Pubmed 21922593
  • Service de Génétique Oncologique, Institut Curie, Paris, France. · Pubmed 21120943
2010
  • Service de Génétique Oncologique, Institut Curie Hôpital, Paris, France. · Pubmed 20721742
  • Preclinical Investigation Unit, Institut Curie - Translational Research Department, Hôpital St Louis, Quadrilatère historique, Porte 13, 1, Ave Claude Vellefaux, Paris 75010, France. · Pubmed 20877358
  • Service de Génétique Oncologique, Institut Curie, 26, rue d'Ulm, 75248 Paris Cedex 05, France. · Pubmed 20842456
2009
  • Génétique oncologique, Institut Curie-Hôpital, 26, rue d'Ulm--75248 Paris, Inserm U830, Université Paris-Descartes. dominique.stoppa-lyonnet@curie-net · Pubmed 20690207
Probable:    Universite Paris 5 Descartes      
2019
  • Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Institut Curie, Université de Recherche Paris Sciences et Lettres, Institut National de la Santé et de la Recherche Médicale U 830, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. Electronic address: · Pubmed 30639725
2018
  • Medical Oncology Department, Paul Strauss Cancer Center, Strasbourg Cedex, France. · Service d'Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Consultation d'Oncogénétique, Département de Médecine Oncologique, Institut Gustave Roussy, Villejuif, France. · Service d'Oncologie Médicale, Centre Catherine de Sienne, Nantes, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · Centre de Génétique, CHU, Dijon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Centre Hospitalier Georges Renon, Pôle Oncologie pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Service d'Oncologie Médicale, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Epidemiology and Biostatistics, Paul Strauss Cancer Center, Strasbourg, France. · Cancer Registry of Bas-Rhin, EA3430, Faculty of medicine, University of Strasbourg, Strasbourg, France. · Pubmed 28929593
  • INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · PSL Research University, Paris, France. · Service de Pathologie, Institut Curie, Paris, France. · INSERM U830, Paris, France. · Service de Génétique, Institut Curie, Paris, France. · Unité de Pharmacogénomique, Institut Curie, Paris, France. · Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie, Paris, France. · CHU Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France. · Unité de Pathologie Gynécologique, Centre François Baclesse, Caen, France. · Service d'Oncologie Génétique, Gustave Roussy, Villejuif, France. · Institut GIMI, CHU de Dijon, Hôpital d'Enfants, Dijon, France. · Oncogénétique, Centre de Lutte contre le Cancer Georges François Leclerc, Dijon, France. · Département d'Hématologie et d'Oncologie Médicale, CLCC Antoine Lacassagne, Nice, France. · Service d'Oncogénétique Régional Poitou-Charentes, Centre Hospitalier Georges-Renon, Niort, France. · Service de Génétique, Clinique Universitaire Saint-Luc, Brussels, Belgium. · Service de Génétique Clinique Guy Fontaine, Hôpital Jeanne de Flandre, Lille, France. · Laboratoire de Diagnostic Génétique, UF1422 Oncogénétique Moléculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Oncogénétique Evaluation familiale et suivi, UF6948 Oncogénétique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. · Laboratoire Maladies Rares: Génétique et Métabolisme, CHU de Bordeaux-GH Pellegrin, Bordeaux, France. · Service d'Oncologie Médicale, Hôpital Universitaire Dupuytren, Limoges, France. · Département de Génétique, Hôpital de la Timone, Marseille, France. · Unité d'Oncogénétique, Centre Paul Strauss, Strasbourg, France. · IUCT Oncopole, Institut Claudius Regaud, Toulouse, France. · Service de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, France. · Unité d'Oncogénétique, ICM Val d'Aurelle, Montpellier, France. · Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · UMR INSERM 1052, Lyon, France. · CNRS 5286, Lyon, France. · Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Université Paris Descartes, Paris, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · PSL Research University, Paris, France. · Pubmed 29665859
  • Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil. · Service de Génétique, Institut Curie, Paris, France. · A.C.Camargo Cancer Center, São Paulo, Brazil. · Laboratoire de Biologie et de Génétique du Cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée, Caen, France. · Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada. · School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia. · Université Paris Descartes, Paris, France. · Service de Génétique, Institut Curie, Paris, France. · Gustave Roussy, Villejuif, France. · Pubmed 29236234
2017
  • Department of Tumour Biology, Institut Curie, Paris, 75005, France. · Inserm U830, Institut Curie, Paris, 75005, France. · Department of Cancer Biology and Genetics, CCC François Baclesse, Caen, 14000, France. · Inserm U1079, Normandy Center for Genomic and Personalized Medicine, Rouen, 76183, France. · University of Caen, Normandie, 14032, France. · Department of Tumour Biology, Institut Curie, Paris, 75005, France. · Inserm U830, Institut Curie, Paris, 75005, France. · Institut Curie, PSL Research University, CNRS UMR3244, Paris, 75005, France. · Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR3244, Paris, 75005, France. · Department of Genetics, Centre Hospitalo-Universitaire, Rennes, 35033, France. · Department of Genetics, Centre François Baclesse, Caen, 14000, France. · Department of Genetics, Centre Hospitalo-Universitaire, Rouen, 76000, France. · University of Rouen, IRIB, Rouen, 76183, France. · Institut Curie, PSL Research University, Paris, 75005, France. · Paris Descartes University, Sorbonne Paris Cité, Paris, 75006, France. · Pubmed 29255180
  • INSERM, U900, Paris, France. · PSL Research University, Paris, France. · Institut Curie, Paris, France. · Mines Paris Tech, Fontainebleau, France. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Service de Génétique, Institut Curie, Paris, France. · CHU de Lyon, Groupement Hospitalier Est, Service de Génétique Médicale, Lyon, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Institut Claudius Regaud-IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Centre Oscar Lambret, Lille, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · CHU de Poitiers, Service de Génétique Médicale, Poitiers, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Clinique Universitaire Saint-Luc, Génétique, Bruxelles, Belgium. · CHU Clermont-Ferrand site Estaing, Clermont-Ferrand, France. · Institut Bergonié, Bordeaux, France. · Hôpital Saint-Joseph, Marseille, France. · Centre François Baclesse, Unité de Pathologie Gynécologique, Caen, France. · Centre Hospitalier Universitaire de Nîmes, Unité de Génétique Médicale et Cytogénétique, Nîmes, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Centre de Recherche en Cancérologie de Lyon, Lyon, France. · UMR INSERM 1052, Lyon, France. · CNRS 5286, Lyon, France. · INSERM, U830, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 28981872
2016
  • Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Institut Bergonié, service de génétique - service de gynécologie, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut Curie, département de chirurgie, 75005 Paris, France. · Institut Curie, Saint-Cloud, service de génétique, 92210 Saint-Cloud, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Université Paris-Descartes, 75006 Paris, France. · Pubmed 26852151
  • Aix Marseille Univ, INSERM, GMGF, Marseille, France. · APHM, Hôpital TIMONE Enfants, Laboratoire de Génétique Moléculaire, Marseille, France. · Laboratory Corporation of America, Westborough, Massachusetts. · Quest Diagnostics, Marlborough, Massachusetts. · Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France. · CHU et Institut Jean Godinot, Reims, France. · Centre Jean Perrin, Clermont-Ferrand, France. · Institut Gustave Roussy, Villejuif, France. · CHU de Nancy-Brabois, Vandoeuvre-lés-Nancy, France. · Groupe hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Laboratoire d'Oncogénétique et Angiogénétique moléculaire, Université Pierre et Marie Curie, Paris, France. · CHU, Institut de Biologie, Hôtel Dieu, Nantes, France. · Université Paris Descartes, Paris, France. · CHU de Dijon, Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Paul Strauss, Strasbourg, France. · Quest Diagnostics, San Juan Capistrano, California. · Centre Oscar Lambret, Unité d'Oncologie Moléculaire Humaine, Lille, France. · Institut Bergonié, Bordeaux, France. · Hospices Civils de Lyon and Centre Léon Bérard, Lyon, France. · Institut Paoli-Calmettes, Marseille, France. · Institut Claudius Régaud, Toulouse, France. · Laboratoire de biologie et de génétique du cancer, CLCC François Baclesse, INSERM 1079 Centre Normand de Génomique et de Médecine Personnalisée, Caen, France. · Laboratoire de Biologie Cellulaire et Hormonale (CHU Arnaud de Villeneuve), Montpellier, France. · Laboratory Corporation of America, Research Triangle Park, North Carolina. · Pubmed 27633797
  • Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN, 37203-1738, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Proteomics Center, CHU de Québec Research Center and Department of Molecular Medicine, Laval University, Quebec, Canada. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK. · Department of Surgery, St Vincent's Hospital, Melbourne, VIC, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico), Padua, Italy. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Department of Pathology, Landspitali University Hospital and BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · McGill University and Génome Québec Innovation Centre, Montréal, Canada. · Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. · Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · International Epidemiology Institute, Rockville, MD, USA. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · K.G. Jebsen Center for Breast Cancer Research, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · International Agency for Research on Cancer, Lyon, France. · Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain. · Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia. · Australian Breast Cancer Tissue Bank, Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea. · Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea. · Cancer Research Institute, Seoul National University, Seoul, South Korea. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Millenium Institute for Medical Research, University of Sydney, Sydney, Australia. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, Muenster, Germany. · Division of Population Sciences, Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · ANZ GOTG Coordinating Centre, Australia New Zealand GOG, Camperdown, NSW, Australia. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel. · Section of Genetic Oncology, Deparment of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Institute of Human Genetics, University Würzburg, Wurzburg, Germany. · INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Genetic Epidemiology of Cancer team, Inserm, U900, Institut Curie, Mines ParisTech, 75248, Paris, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. · University Paris-Sud, Villejuif, France. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. · Department of Surgery, National University Health System, Singapore, Singapore. · Cancer Research Initiatives Foundation, Subang Jaya, Selangor, Malaysia. · Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Suburban Hospital, Bethesda, MD, USA. · Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, MA, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, N, Denmark. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA. · Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Department of Pathology, Oulu University Hospital, University of Oulu, Oulu, Finland. · School of Medicine, National University of Ireland, Galway, Ireland. · Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. · Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research "Demokritos", Athens, Greece. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Vesalius Research Center, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · University of Hawaii Cancer Center, Honolulu, HI, USA. · Department of Surgery, Soonchunhyang University and Hospital, Seoul, South Korea. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Institute of Population Health, University of Manchester, Manchester, UK. · Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Beckman Research Institute of City of Hope, Duarte, CA, USA. · Carbone Cancer Center, University of Wisconsin, Madison, WI, USA. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, CA, USA. · Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · University Hospital Gashuisberg, Leuven, Belgium. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · IFOM, Fondazione Istituto FIRC (Italian Foundation of Cancer Research) di Oncologia Molecolare, Milan, Italy. · Department of Obstetrics and Gynecology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT), Milan, Italy. · Section of Cancer Genetics, The Institute of Cancer Research, London, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel. · Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology (CIO), Center for Molecular Medicine Cologne (CMMC), University Hospital of Cologne, Cologne, Germany. · Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH, USA. · National Cancer Institute, Bangkok, Thailand. · Research Oncology, Guy's Hospital, King's College London, London, UK. · Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany. · Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany. · School of Public Health, China Medical University, Taichung, Taiwan. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia. · Hannover Medical School, Hannover, Germany. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · Department of Clinical Genetics, Odense University Hospital, Odense, C, Denmark. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, QC, Canada. · Currently at Medical School Cambridge University, Cambridge, UK. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland. · Singapore Eye Research Institute, National University of Singapore, Singapore, Singapore. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Peter MacCallum Cancer Center, The University of Melbourne, Melbourne, Australia. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, 8th Floor, Nashville, TN, 37203-1738, USA. · Pubmed 27459855
  • Institut Curie, PSL Research University, Paris, France. · CNRS UMR 3244, Paris, France. · Sorbonne Universités, UPMC Univ Paris 06, Paris, France. · Institut Curie, PSL Research University, Department of Translational Research, the Biophenics High-Content Screening Laboratory, Cell and Tissue Imaging Facility (PICT-IBiSA), Paris, France. · INSERM U981, Villejuif, France. · Univ Paris-Sud, UMR981, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Service de Génétique Oncologique, Institut Curie, Paris, France. · INSERM U830, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 27272900
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, 20133 Padua, Italy. · Department of Health Studies, The University of Chicago, Chicago, Illinois 60637, USA. · Comprehensive Cancer Center, The University of Chicago, Chicago, Illinois 60637, USA. · Departments of Medicine and Human Genetics, The University of Chicago, Chicago, Illinois 60637, USA. · Department of Clinical Genetics, Helsinki University Central Hospital, 00029 Helsinki, Finland. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada M5B 1W8. · Department of Epidemiology, University of California Irvine, Irvine, California, 92697, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Department of Oncology, Karolinska University Hospital, SE-17176 Stockholm, Sweden. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, 20141 Milan, Italy. · Department of Pathology, Landspitali University Hospital and University of Iceland School of Medicine, 101 Reykjavik, Iceland. · Institute for Quality and Efficiency in Health Care (IQWiG), 50670 Cologne, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain. · Genotyping Unit (CeGen), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), 28029 Madrid, Spain. · NYU Women's Cancer Program, New York University School of Medicine, New York, New York 10016, USA. · Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark. · Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany. · University of Tübingen 72074 Tübingen, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, 69120 Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City Utah 84112, USA. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid 28040, Spain. · Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, I-56126 Pisa, Italy. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Australian Breast Cancer Tissue Bank, Westmead Millennium Institute, University of Sydney, Sydney, New South Wales 2145, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850, USA. · Departments of Pediatrics and Medicine, Columbia University, New York, New York 10032, USA. · Center for Medical Genetics, Ghent University, 9000 Ghent, Belgium. · Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. · INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, 69373 Lyon, France. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands. · Oncogenetics Group, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, 08035 Barcelona, Spain. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010, USA. · Cancer Bioimmunotherapy Unit, CRO Aviano National Cancer Institute, 33081 Aviano , Italy. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Pennsylvania 19104, USA. · Department of Genetics, University of Pretoria, Pretoria 0007, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada G1V 4G2. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, Hampshire SO16 6YD, UK. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala SE-751 85, Sweden. · Department of Clinical Genetics, Lund University Hospital, SE-22185 Lund, Sweden. · Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany. · Comprehensive Cancer Center -EMN, 91054 Erlangen, Germany. · Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, 20246 Hamburg, Germany. · Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Center for Primary Health Care Research, Lund University, SE-221 00 Malmö, Sweden. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, 15310 Athens, Greece. · Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada H3A 0G4. · University of, Philadelphia, Pennsylvania 19104, USA. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer 52621, Israel. · Department of Epidemiology, University of, Chapel Hill, North Carolina 27599-7400, USA. · UCLA Schools of Medicine and Public Health, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095-6900, USA. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia 30303, USA. · Cancer Risk and Prevention Clinic, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Biomedical Sciences, Cedars Sinai Medical Center, Los Angeles, California 90048, USA. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3010, Australia. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, 66205, USA. · Department of Medicine, McGill University, Montreal, Quebec, Canada H3G 2M1. · Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada H4A 3J1. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA. · Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850-9772, USA. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, 70-115 Villejuif, France. · Department of of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, SW7 2AZ, UK. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California 90033, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California 91010, USA. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam 1000 BE, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam 3008 AE, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam 3008 AE, The Netherlands. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia. · Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · N.N. Petrov Institute of Oncology, 197758 St Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria 8006, Australia. · Department of Oncology, The University of Melbourne, Melbourne, Victoria 8006, Australia. · State Research Institute Centre for Innovative Medicine, LT-08661 Vilnius, Lithuania. · Department of Clinical Genetics, Aarhus University Hospital, 8200 Aarhus N, Denmark. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California 94538, USA. · Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton SM2 5NG, UK. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, FI-00029 Helsinki, Finland. · Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. · Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53113 Bonn, Germany. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, FI-70211 Kuopio, Finland. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Vesalius Research Center, VIB, 3000 Leuven, Belgium. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, 08908 Barcelona, Spain. · Department of Preventive Medicine, University of Southern California, Los Angeles, California 90032, USA. · Cancer Epidemiology Program, University of Cancer Center, Honolulu, Hawaii 96813, USA. · Department of Molecular Medicine and Surgery, Karolinska Institutet, SE-17177 Stockholm, Sweden. · Health Sciences Research, Mayo Clinic, Scotsdale, Arizona 85259, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. · Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37203, USA. · Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA. · Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98195, USA. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), 20133 Milan, Italy. · Department of Gynaecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany. · NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. · Department of Genomics and Genome Sciences, Case Western Reserve University Medical School, Cleveland, Ohio 44106, USA. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada M5B 1W8. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada M5B 1W8. · Invitae Corporation, San Francisco, California 94107, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. · Department of Molecular Genetics, National Institute of Oncology, H-1122 Budapest, Hungary. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois 60637, USA. · Department of Preventive Medicine and Biomedical Science, Seoul National University College of Medicine and Cancer Research Institute, Seoul National University, 110-799 Seoul, Republic of Korea. · Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht 3508 GA, The Netherlands. · MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2AZ, UK. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, 20133 Milan, Italy. · Divison of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu/Oulu University Hospital, FI-90220 Oulu, Finland. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), 20133 Milan, Italy. · Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, UK. · Department of Clinical Genetics, Karolinska University Hospital, SE-17176 Stockholm, Sweden. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, A 1090 Vienna, Austria. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa 34362, Israel. · Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205, USA. · International Agency for Research on Cancer, 69008 Lyon, France. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam 1006 BE, The Netherlands. · Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, 18014 Granada, Spain. · CIBER de Epidemiología y Salud Pública (CIBERESP), Spain. · Department of Environmental Health Sciences, Columbia University, New York, New York, 10032, USA. · Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London SE1 9RT, UK. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Cologne 50931, Germany. · Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, 50931 Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany. · Division of Genetics, Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales 2305, Australia. · Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City, Kansas 66205, USA. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec City, Quebec, Canada G1V 4G2. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, 69373 Lyon, France. · Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia. · Hannover Medical School, 30625 Hannover, Germany. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, SE-58185 Linköping, Sweden. · Institut Curie, Department of Tumour Biology, 75248 Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, 75248 Paris, France. · National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-2152, USA. · Department of Genetics, Portuguese Oncology Institute, Porto, 4200-072, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, 4200-072 Porto, Portugal. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya 47500, Malaysia. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur 50603, Malaysia. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, 10032, USA. · Department of Clinical Genetics, Odense University Hospital, 5000 Odense C, Denmark. · Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia. · Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, 43210, USA. · Department of Surgical Oncology, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands. · Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, 08908 Barcelona, Spain. · Cancer Registry and Histopathology Unit, 'Civic-M.P. Arezzo' Hospital, 97100 ASP Ragusa, Italy. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, USA. · Cancer Registry of Norway, Institute of Population-Based Cancer Research, N-0304 Oslo, Norway. · Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam 3000 CA, The Netherlands. · Institute of Human Genetics, Charite Berlin, 13353 Berlin, Germany. · Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, Maryland 20877, USA. · University Hospital Ulm, 89075 Ulm, , Germany. · Department of Community Medicine, Faculty of Health Sciences, University of Tromsø-The Arctic University of Norway, 9037 Tromsø, Norway. · Genetic Epidemiology Group, Folkhälsan Research Center, 2016 Helsinki, Finland. · Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California 94305, USA. · Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals, B-3000 Leuven, Belgium. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. · Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain. · Department of Biostatistics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850, USA. · Pubmed 27117709
  • Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Breast Cancer Research, Breakthrough Breast Cancer Research Centre, London, UK. · Academic Biochemistry, Royal Marsden Hospital, London, UK. · Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. · Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK. · Institute of Population Health, University of Manchester, Manchester, UK. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg Metropolitan Region, Erlangen, Germany. · Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, London, UK. · Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK. · Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center, Heidelberg, Germany. · National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. · University Paris-Sud, Villejuif, France. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. · Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain. · Department of Epidemiology, University of California-Irvine, Irvine, California, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. · German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany. · Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany. · Centre of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology, University Hospital, Cologne, Germany. · Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Oncology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan. · Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan. · Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. · Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden. · Cancer Center, Kuopio University Hospital, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Vesalius Research Center, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Multidisciplinary Breast Center, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Unit of Molecular Basis of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. · Department of Medicine, McGill University, Montreal, Quebec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. · Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. · Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway. · Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab Oulu University Hospital, Oulu, Finland. · Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland. · Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China. · Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · International Epidemiology Institute, Rockville, Maryland, USA. · Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. · Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. · Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Department of Haematology-Oncology, National University Health System, Singapore. · Cancer Science Institute of Singapore, National University of Singapore, Singapore. · Saw Swee Hock School of Public Health, National University of Singapore, Singapore. · Department of Surgery, National University Health System, Singapore. · Institute of Human Genetics, Pontificia Universidad Javerianar, Bogota, Colombia. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · International Agency for Research on Cancer, Lyon, France. · National Cancer Institute, Bangkok, Thailand. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. · School of Public Health, China Medical University, Taichung, Taiwan. · Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. · Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. · Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, Institute of Cancer Research, London, UK. · Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Latvian Biomedical Research and Study Centre, Riga, Latvia. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milan, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, University La Sapienza, Rome, Italy. · Molecular Diagnostics Laboratory, INRASTES (Institute of Nuclear and Radiological Sciences and Technology), National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. · Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, UK. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian Albrechts University Kiel, Kiel, Germany. · University Düsseldorf, Dusseldorf, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Gynaecology and Obstetrics and Centre for Integrated Oncology, Center for Molecular Medicine Cologne, University Hospital of Cologne, Cologne, Germany. · Institute of Human Genetics, Münster, Germany. · INSERM U1052, CNRS UMR 5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC (El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong. · Department of Surgery, University of Hong Kong, Hong Kong. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Breast Cancer and Systems Biology Unit, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, Barcelona, Spain. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Medical Genetic Division, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada. · Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada. · Masaryk Memorial Cancer Institute and Medical Faculty, Masaryk University, Brno, Czech Republic. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA. · Department of Community Medicine and Epidemiology, Carmel Medical Center and B. Rappaport Faculty of Medicine, Haifa, Israel. · Clalit National Israeli Cancer Control Center, Haifa, Israel. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Center for Medical Genetics, NorthShore University Health System, Evanston, Illinois, USA. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York, USA. · Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. · Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel. · Department of Oncology, Lund University, Lund, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California Los Angeles School of Medicine and School of Public Health, Los Angeles, California, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, California, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. · University of Hawaii Cancer Center, Honolulu, Hawaii, USA. · Department of Obstetrics, Gynaecology and Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada. · Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, Western Australia, Australia. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts, USA. · Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Pubmed 26928228
  • Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Peter MacCallum Cancer Institute, East Melbourne, Australia. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. · Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia. · Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · UPMC Cancer Center, Pittsburgh, PA, USA. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA. · Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Medicine and Genetics, University of California, San Francisco, San Francisco, CA, USA. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, IL, USA. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Malaysia. · University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Section of Genetic Oncology, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark. · Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine, The Ohio State University, Columbus, OH, USA. · Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Center for Medical Genetics, North Shore University Health System, Evanston, IL, USA. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Urology, Medical University of Vienna, Vienna, Austria. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. · Department of Oncology, Mayo Clinic, Rochester, MN, USA. · Department of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA. · Department of Surgery, Daerim St. Mary's Hospital, Seoul, Korea. · Department of Genetics, Portuguese Institute of Oncology, Porto, Portugal. · Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. · Department of Genetics, Portuguese Institute of Oncology, Porto, Portugal. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS (Scientific Institute of Hospitalization and Care), Padua, Italy. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS (Scientific Institute of Hospitalization and Care), Padua, Italy. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Oncology, Landspitali University Hospital and Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, Landspitali University Hospital and Biomedical Centre (BMC), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Genetic Counseling Unit, Hereditary Cancer Program, Biomedical Research Institute of Girona (IDIBGI), Catalan Institute of Oncology, Girona, Spain. · Breast Cancer and Systems Biology Unit, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Oncogenetics Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Pathology, National Institute of Oncology, Budapest, Hungary. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, China. · Department of Surgery, The University of Hong Kong, Hong Kong, China. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. · Department of Oncology, San Carlos Clinical Hospital Health Research Institute (IdISSC), San Carlos Clinical Hospital, Madrid, Spain. · Molecular Oncology Laboratory, San Carlos Clinical Hospital Health Research Institute (IdISSC), San Carlos Clinical Hospital, Madrid, Spain. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Tumour Biology, Institut Curie, Paris, France. · CNRS UMR5558, Université Lyon 1, Lyon, France. · Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Université Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Department of Gynaecology and Obstetrics, Technical University of Munich, Munich, Germany. · Institute of Human Genetics, University of Wurzburg, Wurzburg, Germany. · Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics and Epidemiology University of Leipzig, Leipzig, Germany. · University of Dusseldorf, Dusseldorf, Germany. · Hannover Medical School, Hannover, Germany. · Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany. · Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany. · Department of Gynaecolgy and Obstetrics, University Hospital of Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany. · Institute of Human Genetics, Charité, Berlin, Germany. · Institute of Human Genetics, Leipzig, Germany. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Yorkshire Regional Genetics Service, Leeds, UK. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA. · Molecular Diagnostics Laboratory, Institute of Nuclear and Radiological Sciences and Technology (INRASTES), National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece. · Department of Medical Science, University of Turin, Turin, Italy. · AO Città della Salute e della Scienza, Turin, Italy. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Section of Medical Oncology, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy. · Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Scientific Institute of Hospitalization and Care), AOU San Martino - IST National Institute for Cancer Research, Genoa, Italy. · Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy. · Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy. · Unit of Genetic Counselling, Medical Oncology Department, Regina Elena National Cancer Institute, Rome, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), 20133, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, IRCCS (Scientific Institute of Hospitalization and Care), National Cancer Institute (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Milan, Italy. · Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), Milan, Italy. · Division of Experimental Oncology, CRO Aviano National Cancer Institute, Aviano, PN, Italy. · IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · National Cancer Institute "Giovanni Paolo II", Bari, Italy. · IFOM, FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. · Clinical Cancer Genetics, City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Human Genotyping (CEGEN) Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA. · Department of Pathology & Molecular Medicine, Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada. · Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, UK. · Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy. · Pubmed 26857456
  • Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines ParisTech, Fontainebleau, France. · Département de Médecine Oncologique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Institut Curie, Service de Génétique, Paris, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Centre Oscar Lambret, Lille, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · CH Georges Renon, Service Oncogénétique pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Centre Eugène Marquis, Service de Génétique, Rennes, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · Inserm, U830, Université Paris-Descartes, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard, Lyon, France. · Pubmed 26785832
  • Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Institut Curie, Service de Génétique, Paris, France. · Institut de Cancérologie Gustave Roussy, Service d'Oncologie Génétique, Villejuif, France. · Institut Curie, Service de Génétique, Paris, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · ICM Val d'Aurel, Unité d'Oncogénétique, Montpellier, France. · Institut Curie, Service de Génétique, Paris, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · Centre Eugène-Marquis, Service de Génétique, Rennes, France. · CH Georges Renon, Service Oncogénétique pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Hôpital d'Enfants, Service de Génétique Médicale, Dijon, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. · ICL Alexis Vautrin, Unité d'Oncogénétique, Vandœuvre-lès-Nancy, France. · Centre François Baclesse, Unité de pathologie gynécologique, Caen, France. · Centre René Gauducheau, Unité d'Oncogénétique, Nantes Saint Herblain, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Hôpitaux Universitaires de Strasbourg, UF1422 Oncogénétique moléculaire, Laboratoire de diagnostic génétique, Strasbourg, France. · Hôpitaux Universitaires de Strasbourg, UF6948 Oncogénétique, Service d'Hémato-Oncologie, Strasbourg, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. · Inserm, U896, CRCM Val d'Aurel, Montpellier, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Institut Bergonié, Bordeaux, France. · Centre Jean-Perrin, Clermont-Ferrand, France. · Centre Oscar-Lambret, Lille, France. · Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France. · Polyclinique Courlancy, Reims, France. · Clinique Sainte Catherine, Avignon, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Institut Claudius Regaud - IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Hôpital Bretonneau, Service de Génétique, Tours, France. · CHU Brest, Hôpital Morvan, Département de génétique médicale en pédiatrie, Brest, France. · Hôpital Tenon, Paris, France. · Hôpital Edouard Herriot, Service de Génétique Moléculaire, Lyon, France. · Hôpital Jeanne de Flandre, Service de génétique clinique Guy Fontaine, Lille, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Hôpital Pasteur, Service d'Onco-hématologie, Colmar, France. · CHRU Hôpital Caremeau, Nîmes, France. · Hôpital Tenon, Service d'Oncogénétique, Paris, France. · Institut Bergonié, Bordeaux, France. · IPC, Département d'Anticipation et de Suivi des Cancers, Marseille, France. · Inserm, UMR 912, Marseille, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, APHP, Paris, France. · Centre Hospitalier de Chambéry, Chambéry, France. · Institut Jean-Godinot, Reims, France. · ICC Courlancy, Cs Oncogénétique, Reims, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · CHU Hôpital Saint-Jacques, Service Génétique et Biologie du Développement - Histologie, Besançon, France. · Institut Bergonié, Bordeaux, France. · Hôpital Flaubert, Le Havre, France. · CHU de Grenoble, Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Hôpital Saint-Louis, Paris, France. · CHU de Saint-Etienne, Hôpital Nord, Service de Génétique, Saint-Etienne, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Hôpital Lariboisière, Centre Viggo-Petersen, Paris, France. · CHU Hôpital de Brabois, Laboratoire de Génétique, Vandœuvre-lès-Nancy, France. · CHU de Martinique, Unité d'Oncogénétique, Fort-de-France, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Institut Curie, Département d'imagerie médicale, Paris, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Cancer Research Centre of Lyon, CNRS UMR5286, Inserm U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · PSL Research University, Paris, France. · Institut Curie, Service de Génétique, Paris, France. · Inserm, U830, Paris, France. · Université Paris-Descartes, Paris, France. · Inserm, U900, Paris, France. · Institut Curie, Paris, France. · PSL Research University, Paris, France. · Mines ParisTech, Fontainebleau, France. · Pubmed 26758370
  • Centre De Recherche, Institut Curie, Paris, F-75248, France. · INSERM U830, Paris, F-75248, France. · Département De Biologie Des Tumeurs, Institut Curie, Paris, F-75248, France. · Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, K7L 3N6, Canada. · Centre De Ressources Biologiques, Institut Curie, Paris, F-75248, France. · Département De Recherche Translationnelle, Institut Curie, Paris, F-75248, France. · Sorbonne Paris Cité, University Paris-Descartes, Paris, F-75270, France. · Pubmed 26317927
  • Institut Curie, Département de Biopathologie, Paris, France. · Institut Curie, Inserm U830, Paris, France. · CHU Nantes, Service de Génétique médicale, Nantes, France. · Pôle Oncologie, Oncogénétique Poitou-Charentes, Niort, France. · CHU Angers, Service de Génétique médicale, Angers, France. · Université de Nantes, Faculté de Médecine de Nantes, Nantes, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Faculté des Sciences pharmaceutiques et biologiques, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Pubmed 26028024
  • Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France. · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Genetics, Institut Curie, Paris Descartes University, Paris, France. · Pubmed 26846839
2015
  • "Genetics of Breast Cancer" Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · Unité d'Oncologie Génétique, Centre Paul Strauss, Strasbourg, France. · "Genetics of Breast Cancer" Team, Cancer Research Centre of Lyon, CNRS UMR5286/Inserm U1052/Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM, U900, Paris, France. · Institut Curie, Paris, France. · Mines ParisTech, Fontainebleau, France. · Service d'Oncologie Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Service de Génétique, Institut Curie, Paris, France. · Unité d'Oncogénétique, ICL Alexis Vautrin, Vandœuvre-lès-Nancy, France. · Unité de Pathologie Gynécologique, Centre François Baclesse, Caen, France. · Service Oncologie Médicale, Centre René Gauducheau, Nantes Saint Herblain, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. · CNRS UMR 5558, Lyon, France. · Unité de Prévention et Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Service d'Oncologie, UF6948, Hôpital Civil, Strasbourg, France. · Service de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France. · INSERM U896, CRCM Val d'Aurel, Montpellier, France. · Institut Bergonié, Bordeaux, France. · Centre Jean-Perrin, Clermont-Ferrand, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Centre Léon Bérard, Lyon, France. · Inserm, U830, Paris, France. · Université Paris-Descartes, Paris, France. · Unité d'Oncologie Génétique, Centre Paul Strauss, Strasbourg, France. · Pubmed 26564480
  • CERMES3, 7, rue Guy Môquet, 94801 Villejuif, France. · Institut Curie, Université Paris Descartes, 26, rue d'Ulm, 75248 Paris, France. · Pubmed 25744269
2017
  • Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy. · Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California, Irvine, Irvine, California, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. · Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Institute of Human Genetics, Hannover Medical School, Hannover, Germany. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy. · McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada. · Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Bâtiment Cheney D, Centre Léon Bérard, Lyon, France. · Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Spanish Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · International Epidemiology Institute, Rockville, Maryland, USA. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Gustave Roussy, Biopathology Department, Villejuif, France. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain. · Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) and Centro Nacional de Genotipado (CEGEN-PRB2), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain. · Centre François Baclesse, Caen, France. · Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University of Münster, Münster, Germany. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genetics Department, Dijon University Hospital, Dijon, France. · Oncogenetics, Centre Georges-François Leclerc, Dijon, France. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada. · Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Medicine, McGill University, Montréal, Québec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada. · Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Pubmed 29058716
2016
  • Department of Tumour Biology, Institut Curie, Paris, France. · INSERM U830, Institut Curie, Paris, France. · Department de Génétique, Université Paris Descartes, Service de Génétique, Institut Curie, Paris, France. · Pubmed 27514841
2015
  • INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Centre Catherine de Sienne, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Département de Cancérologie sénologique, CLCC Oscar Lambret, Lille, France. · Centre François Baclesse, Caen, France. · Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Université Lyon 1, CNRS UMR5558, Lyon, France; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France. · Université Lyon 1, INCa-Synergie, Centre Léon Bérard, 28 rue Laennec, Lyon Cedex 08, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · Pubmed 26406445
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. · Genome Instability and DNA Repair Group, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona and Center for Biomedical Network Research on Rare Diseases (CIBERER), Barcelona, Spain. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Department of Experimental Oncology and Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. · Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany, Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · INSERM, U900, Paris, France, Institut Curie, Paris, France, Mines ParisTech, Fontainebleau, France. · Service de Génétique Oncologique, Institut Curie, Paris, France, INSERM, U830, Paris, France, Université Paris-Descartes, Paris, France. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France, Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France. · Familial Cancer Centre, Sir Peter MacCallum Department of Oncology and. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and. · Department of Immunohematology and Transfusion Medicine and. · Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy, Institute of Medical Genetics, 'A. Gemelli' School of Medicine, Catholic University, Rome, Italy. · Dipartimento di Oncologia, Ematologia e Malattie dell'Apparato Respiratorio, Università di Modena e Reggio Emilia, Modena, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Cancer Bio-Immunotherapy Unit and. · Unit of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Unit of Hereditary Cancers, IRCCS AOU San Martino - IST, Genoa, Italy. · Medical Genetics, University of Siena, Siena, Italy, Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · SC Medical Genetics, ASl8 Cagliari, Cagliari, Italy. · Unit of Pathology, Ospedale di Circolo, Varese, Italy. · Section of Genetic Oncology, University Hospital and University of Pisa, Pisa, Italy. · IRCCS Istituto Tumori 'Giovanni Paolo II', Molecular Genetics Laboratory, Bari, Italy. · Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain, Spanish Genotyping Centre (CEGEN), Madrid, Spain. · Scientific Directorate and. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics, Department of Pathology and. · Department of Human Genetics. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Oncogenetics Group, Hospital Universitari de la Vall d'Hebron, Barcelona, Spain, Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain. · Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Department of Medical Oncology, Hospital Universitari de la Vall d́Hebron, Barcelona, Spain. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy. · Catalan Institute of Oncology - IDIBELL, Barcelona, Spain. · Clinical Genetics Service, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Oncology, Department of Clinical Sciences. · Department of Clinical Genetics, Laboratory Medicine, Office for Medical Services and Department of Clinical Genetics, Lund University, Lund, Sweden. · Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 26130695
  • Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America. · Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh. · Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America. · Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain. · All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom. · All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom. · Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands. · Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America. · Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America. · Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America. · Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy. · Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy. · Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece. · Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Women's College Research Institute, University of Toronto, Toronto, Canada. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel. · The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · N.N. Petrov Institute of Oncology, St.-Petersburg, Russia. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America. · The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France. · Centre François Baclesse, Caen, France. · Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France. · Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Pubmed 25830658
  • Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. Inserm, U830, Paris, France. Université Paris-Descartes, Paris, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. CNRS UMR 5558, Lyon, France. Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Centre François Baclesse, Unité de pathologie gynécologique, Caen, France. · Institut de Cancérologie Gustave Roussy, Service d'Oncologie Génétique, Villejuif, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. Hôpital d'enfants, Service de Génétique Médicale, Dijon, France. · CH Georges Renon, Pôle Oncologie pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · IPC, Département d'Anticipation et de Suivi des Cancers, Marseille, France. INSERM, UMR 912, Marseille, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Institut Claudius Regaud-IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · ICL Alexis Vautrin, Unité d'Oncogénétique, Vandœuvre-lès-Nancy, France. · Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France. · Nouvel Hôpital Civil, Laboratoire de Diagnostic Génétique, Strasbourg, France. · Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, APHP, Paris, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Pubmed 25613119
  • IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany, on behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC). · Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, United Kingdom. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia. · Department of Pathology, University of Otago, Christchurch, New Zealand. · Department of Biomedical Sciences and Medicine, Gambelas Campus, University of Algarve, Portugal. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Clinical Genetics, MUMC, Maastricht, the Netherlands. · Center for Clinical Cancer Genetics, Department of Medicine and Human Genetics, University of Chicago Medical Center, Chicago, Illinois. · Department of Medicine and Institute for Human Genetics, University of California, San Francisco, San Francisco, California. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Departments of Pediatrics and Medicine, Columbia University, New York, New York. · Department of Genetics and Genomics at Case Western Reserve Medical School, Cleveland, Ohio. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Dept. of Molecular and Regenerative Medicine; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Molecular Genetics Laboratory, Department of Biochemistry, Cruces Hospital Barakaldo, 48903-Barakaldo-Bizkaia, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Saint Alphonsus Regional Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California (for the City of Hope Clinical Cancer Genetics Community Research Network). · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Department of Molecular Medicine, Sapienza University, Rome, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental, and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Genetic Counseling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · UO Anatomia Patologica Ospedale di Circolo e Fondazione Macchi, Polo Universitario Varese, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Dana-Farber Cancer Institute, Boston, Massachuestts. · Clinical Genetics Department, St. Michael's Hospital, Bristol, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · University of Southampton, Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin, Ireland. St. James's Hospital, Dublin, Ireland. · All Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · Centre for Cancer Research and Cell Biology, Queens University of Belfast, Department of Medical Genetics, Belfast HSC Trust, Belfast, United Kingdom. · West of Scotland Regional Genetics Service, Southern General Hospital, Glasgow, United Kingdom. · Medical Genetics Unit, St. George's, University of London, London, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Missouri. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Germany. · Institute of Human Genetics, University Würzburg, Wurzburg, Germany. · University Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany. · University Düsseldorf, Dusseldorf, Germany. · Hannover Medical School, Hanover, Germany. · Institute of Human Genetics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany. · Department of Gynaecology and Obstetrics, University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Institute of Human Genetics, Charite Berlin, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany. · INSERM U946, Fondation Jean Dausset, Paris, France. Service de Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Centre René Gauducheau, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. Institut Curie, INSERM U830, Paris, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Department of Medical Oncology, Centre Hospitalier Universitaire Dupuytren, Limoges, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York. · Australia New Zealand Gynaecological Oncology Group (ANZGOG), Coordinating Centre, Camperdown, Australia. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois. · Ohio State University, Department of Obstetrics and Gynecology, Hilliard, Ohio. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands. · Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands. · Department of Human Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands. · Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Erasmus University MC Cancer Institute, Rotterdam, the Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Group, University Hospital Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Centre de Recherche FRSQ du Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Health Sciences Research, Mayo Clinic, Scottsdale, Arizona. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnessotta. · National Human Genome Research Institute, NIH, Bethesda, Maryland. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Diagnostic Molecular Genetics Laboratory, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland. · Clalit National Cancer Control Center, Haifa, Israel. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Sheba Medical Center, Tel Aviv, Israel. · Pubmed 25336561
2014
  • Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece. · Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain. · Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America. · Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America. · Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy. · Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom. · South West Regional Genetics Service, Bristol, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Prince of Wales Hospital. Sydney, Australia. · Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America. · For Tufts Medical Center, Boston, Massachusetts, United States of America. · Yale University School of Medicine, New Haven, Connecticut, United States of America. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands. · Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland. · Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia. · Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America. · Clalit National Israeli Cancer Control Center, Haifa, Israel. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · Pubmed 24698998
  • 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France. · INSERM U900, Mines Paris Tech, Centre de Recherche de l'Institut Curie, Paris, France. · Service de Génétique Oncologique, Institut Curie, Paris, France. · Next Generation Sequencing Platform, Centre de Recherche de l'Institut Curie, Paris, France. · 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Pubmed 23942203
2013
  • Supportive Care Department, University Paris Descartes, Paris, France. · Pubmed 23462725
2012
  • Centre de Recherche, University Paris-Descartes, Paris, France. · Pubmed 22933060
2009
  • Génétique oncologique, Institut Curie-Hôpital, 26, rue d'Ulm--75248 Paris, Inserm U830, Université Paris-Descartes. dominique.stoppa-lyonnet@curie-net · Pubmed 20690207
Probable:    Sorbonne University      
2019
  • Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Institut Curie, Université de Recherche Paris Sciences et Lettres, Institut National de la Santé et de la Recherche Médicale U 830, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Paris, France. · Department of Tumor Biology, Institut Curie, Université de Recherche Paris Sciences et Lettres, Paris, France. Electronic address: · Pubmed 30639725
2016
  • Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Institut Bergonié, service de génétique - service de gynécologie, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address: · Institut Curie, département de chirurgie, 75005 Paris, France. · Institut Curie, Saint-Cloud, service de génétique, 92210 Saint-Cloud, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France. · Institut Curie, service de génétique, 26, rue d'Ulm, 75248 Paris cedex 5, France; Université Paris-Descartes, 75006 Paris, France. · Pubmed 26852151
  • Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France. · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Claude Bernard University, Lyon, France · Dept of Respiratory Medicine, Groupement Hospitalier Est, Lyon, France Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Dept of Genetics, Institut Curie, Paris Descartes University, Paris, France. · Pubmed 26846839
2015
  • CERMES3, 7, rue Guy Môquet, 94801 Villejuif, France. · Institut Curie, Université Paris Descartes, 26, rue d'Ulm, 75248 Paris, France. · Pubmed 25744269
2017
  • Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. · Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. · Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Donnelly Centre, University of Toronto, Toronto, Ontario, Canada. · Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Québec, Canada. · Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. · Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), IRCCS, Padua, Italy. · Center for Cancer Epidemiology and Prevention, University of Chicago, Chicago, Illinois, USA. · Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Personalised Medicine Team, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · Roswell Park Cancer Institute, Buffalo, New York, USA. · Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, USA. · Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. · Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. · Department of Epidemiology, University of California, Irvine, Irvine, California, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Institute of Clinical Molecular Biology / Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany. · Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. · Institute of Human Genetics, Hannover Medical School, Hannover, Germany. · Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. · Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori (INT), Milan, Italy. · McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada. · Department of Medical Oncology, University Hospital, Vall d'Hebron, Barcelona, Spain. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Bâtiment Cheney D, Centre Léon Bérard, Lyon, France. · Laboratory of Cell Biology, Department of Pathology, Landspitali, Reykjavik, Iceland. · BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Human Genotyping Unit -Centro Nacional de Genotipado (CEGEN), Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Spanish Network on Rare Diseases (CIBERER), Madrid, Spain. · Institute of Biochemistry and Genetics, Ufa Scientific Center of the Russian Academy of Sciences, Ufa, Russian Federation. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA. · Université Clermont Auvergne, INSERM, U1240, Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, Clermont-Ferrand, France. · Clinical Cancer Genetics, City of Hope, Duarte, California, USA. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands. · Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. · International Epidemiology Institute, Rockville, Maryland, USA. · City of Hope Clinical Cancer Genomics Community Research Network, Duarte, California, USA. · Vesalius Research Center, VIB, Leuven, Belgium. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium. · Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. · University of Tübingen, Tübingen, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · Gustave Roussy, Biopathology Department, Villejuif, France. · Department of Clinical Genetics, Royal Devon and Exeter Hospital, Exeter, UK. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. · Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany. · Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Medical Oncology Department, CIBERONC, Hospital Clínico San Carlos, Madrid, Spain. · Section of Molecular Genetics, Department of Laboratory Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy. · Research Department, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servizo Galego de Saúde SERGAS, Santiago de Compostela, Spain. · Centro de Investigación en Red de Enfermedades Raras (CIBERER) and Centro Nacional de Genotipado (CEGEN-PRB2), Universidade de Santiago de Compostela, Santiago de Compostela, Spain. · Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA. · Oncology and Genetics Unit, Instituto de Investigación Biomédica (IBI) de Orense-Pontevedra-Vigo, Xerencia de Xestión Integrada de Vigo, Servizo Galego de Saúde SERGAS, Vigo, Spain. · Centre François Baclesse, Caen, France. · Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. · University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Hôpital du Saint-Sacrement, Québec City, Québec, Canada. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. · Huntsman Cancer Institute, Salt Lake City, Utah, USA. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. · Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. · Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. · Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. · INSERM U1052, Cancer Research Center of Lyon, Lyon, France. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA. · Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, UK. · Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Clinical and Molecular Genetics Area, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Gynecology and Obstetrics, Ludwig Maximilians University of Munich, Munich, Germany. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. · Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. · Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. · Institute of Human Genetics, University of Münster, Münster, Germany. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. · Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. · Genetics Department, Dijon University Hospital, Dijon, France. · Oncogenetics, Centre Georges-François Leclerc, Dijon, France. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Usher Institute of Population Health Sciences and Informatics, CRUK Edinburgh Centre, University of Edinburgh Medical School, Edinburgh, UK. · Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. · Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. · Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada. · Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · School of Public Health, Curtin University, Perth, Western Australia, Australia. · Clinical Cancer Genetics Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, Schools of Medicine and Public Health, University of California, Los Angeles, Los Angeles, California, USA. · Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. · Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. · Department of Medicine, McGill University, Montréal, Québec, Canada. · Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada. · Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA. · Department of Obstetrics and Gynecology, Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Montréal, Québec, Canada. · Department of Obstetrics and Gynaecology and Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria. · Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. · Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Biostatistics and Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. · Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. · Pubmed 29058716
2016
  • Leuven Cancer Institute, KU, Leuven, European Union, Belgium. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. · Department of Clinical Genetics, Copenhagen University Hospital, Denmark. · Department of Clinical Genetics, Leiden University Medical Center, Netherlands. · Innsbruck Medical University, Austria. · Portuguese Institute of Oncology, Lisbon, Portugal. · Department of Medical Oncology, CRLCC Léon Bérard, University Claude Bernard Lyon, France. · Institut Curie, Department of Tumour Biology, Paris, France; Charité University of Medicine Berlin, Germany; University of Milan-Bicocca, and European Institute of Oncology, Italy. · Institut Curie, INSERM U830, Paris, France. · Université Paris Descartes, Sorbonne Paris Cité, France. · MD Anderson Cancer Center Madrid, Spain. · Pubmed 27821315
  • Department of Tumour Biology, Institut Curie, Paris, France. · INSERM U830, Institut Curie, Paris, France. · Department de Génétique, Université Paris Descartes, Service de Génétique, Institut Curie, Paris, France. · Pubmed 27514841
2015
  • INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France. · Inserm, U900, Paris, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Centre Catherine de Sienne, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Département de Cancérologie sénologique, CLCC Oscar Lambret, Lille, France. · Centre François Baclesse, Caen, France. · Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France. · Université Lyon 1, CNRS UMR5558, Lyon, France; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France. · Université Lyon 1, INCa-Synergie, Centre Léon Bérard, 28 rue Laennec, Lyon Cedex 08, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · Pubmed 26406445
  • IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine. · Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada. · Genome Instability and DNA Repair Group, Department of Genetics and Microbiology, Universitat Autònoma de Barcelona and Center for Biomedical Network Research on Rare Diseases (CIBERER), Barcelona, Spain. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France. · Department of Experimental Oncology and Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy, Cogentech, Cancer Genetic Test Laboratory, Milan, Italy. · Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany. · Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. · Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University Hospital Heidelberg, Heidelberg, Germany, Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany. · INSERM, U900, Paris, France, Institut Curie, Paris, France, Mines ParisTech, Fontainebleau, France. · Service de Génétique Oncologique, Institut Curie, Paris, France, INSERM, U830, Paris, France, Université Paris-Descartes, Paris, France. · Cancer Research Centre of Lyon, CNRS UMR5286, INSERM U1052, Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France, Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon/Centre Léon Bérard, Lyon, France. · Familial Cancer Centre, Sir Peter MacCallum Department of Oncology and. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and. · Department of Immunohematology and Transfusion Medicine and. · Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy, FiorGen Foundation for Pharmacogenomics, Sesto Fiorentino, Italy, Institute of Medical Genetics, 'A. Gemelli' School of Medicine, Catholic University, Rome, Italy. · Dipartimento di Oncologia, Ematologia e Malattie dell'Apparato Respiratorio, Università di Modena e Reggio Emilia, Modena, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Cancer Bio-Immunotherapy Unit and. · Unit of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Unit of Hereditary Cancers, IRCCS AOU San Martino - IST, Genoa, Italy. · Medical Genetics, University of Siena, Siena, Italy, Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine. · Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. · SC Medical Genetics, ASl8 Cagliari, Cagliari, Italy. · Unit of Pathology, Ospedale di Circolo, Varese, Italy. · Section of Genetic Oncology, University Hospital and University of Pisa, Pisa, Italy. · IRCCS Istituto Tumori 'Giovanni Paolo II', Molecular Genetics Laboratory, Bari, Italy. · Unit of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · Human Cancer Genetics Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain, Spanish Genotyping Centre (CEGEN), Madrid, Spain. · Scientific Directorate and. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics, Department of Pathology and. · Department of Human Genetics. · Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Oncogenetics Group, Hospital Universitari de la Vall d'Hebron, Barcelona, Spain, Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain. · Vall d́Hebron Institute of Oncology (VHIO), Barcelona, Spain, Department of Medical Oncology, Hospital Universitari de la Vall d́Hebron, Barcelona, Spain. · Center for Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany. · Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Università di Firenze, Firenze, Italy. · Catalan Institute of Oncology - IDIBELL, Barcelona, Spain. · Clinical Genetics Service, Department of Medicine and Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Cancer Genetics Laboratory and Sir Peter MacCallum Department of Oncology and Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Division of Oncology, Department of Clinical Sciences. · Department of Clinical Genetics, Laboratory Medicine, Office for Medical Services and Department of Clinical Genetics, Lund University, Lund, Sweden. · Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Pubmed 26130695
  • Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Epidemiological Study of Familial Breast Cancer (EMBRACE), Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. · Statistics Unit, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America. · Breast Cancer and Systems Biology Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Genetics and Biodiversity Research Institute (IRBio), University of Barcelona, Barcelona, Catalonia, Spain. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, Bangladesh. · Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Catalonia, Spain. · Hereditary Cancer Program, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Hospital Josep Trueta, Girona, Catalonia, Spain. · Human Genetics Group, Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases, Madrid, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Maryland, Rockville, United States of America. · Department of Medicine and Genetics, University of California San Francisco, San Francisco, California, United States of America. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Department of Pathology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Research Institute (VHIR) and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Molecular Oncology Laboratory, Hospital Clínico San Carlos, San Carlos Research Institute (IdISSC), Madrid, Spain. · All Wales Medical Genetics Service, Glan Clwyd Hospital, Rhyl, United Kingdom. · All Wales Medical Genetics Services, Singleton Hospital, Swansea, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals National Health Service (NHS) Foundation Trust, Manchester, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare National Health Service (NHS) Trust, Edgbaston, Birmingham, United Kingdom. · Department of Genetics, Portuguese Oncology Institute, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Family Cancer Clinic, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands. · Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics and Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Centre, Amsterdam, The Netherlands. · Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Division of Gynecologic Oncology, NorthShore University HealthSystem, University of Chicago, Chicago, Illinois, United States of America. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Central Connecticut Cancer Consortium, Hartford Hospital/Helen and Harry Gray Cancer Center, Hartford, Connecticut, United States of America. · Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America. · Division of Gynecologic Oncology, Ohio State University, Columbus Cancer Council, Hilliard, Ohio, United States of America. · Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, Connecticut, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynecology and Obstetrics, Division of Tumor Genetics, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Ludwig-Maximilian University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Institute of Human Genetics, Christian-Albrechts-University of Kiel University Medical Center Schleswig-Holstein, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Fondazione Istituto di Oncologia Molecolare (IFOM), Fondazione Italiana per la Ricerca sul Cancro (FIRC), Milan, Italy. · Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Istituto Nazionale Tumori (INT), Milan, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto (IOV), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua, Italy. · Laboratoire de Diagnostic Génétique et Service d'Onco-Hématologie, Hopitaux Universitaire de Strasbourg, Centre Hospitalier Régional Universitaire (CHRU) Nouvel Hôpital Civil, Strasbourg, France. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Department of Gynecology and Obstetrics, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, United States of America. · Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative medicine, Vilnius, Lithuania. · Cancer Genetics Laboratory, Department of Genetics, University of Pretoria, Arcadia, South Africa. · Molecular Diagnostics Laboratory, Institute of Radioisotopes and Radiodiagnostic Products (IRRP), National Centre for Scientific Research Demokritos, Athens, Greece. · Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Women's College Research Institute, University of Toronto, Toronto, Canada. · Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel. · The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel. · The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · N.N. Petrov Institute of Oncology, St.-Petersburg, Russia. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, Australia. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · St. Joseph Hospital of Orange, Care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California, United States of America. · The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network, Toronto, Canada. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Catalonia, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain. · Cancer Epigenetics and Biology Program (PEBC), IDIBELL, L'Hospitalet del Llobregat, Catalonia, Spain. · Department of Tumour Biology, Institut Curie, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France. · Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Tumour Biology, Institut Curie, Paris, France. · Université Lyon 1, Centre National de la Recherche Scientifique (CNRS) UMR5558, and Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France. · Laboratoire de Génétique Chromosomique, Hôtel Dieu Centre Hospitalier, Chambéry, France. · Centre François Baclesse, Caen, France. · Genetic Unit, Avicenne Hospital, Assitance Publique-Hôpitaux de Paris, Paris, Sud-Francilien Hospital, Evry-Corbeil, and University Hospital, Clermont-Ferrand, France. · Département d'Oncogénétique, Centre Jean Perrin, Université de Clermont-Ferrand, Clermont-Ferrand, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon-Centre Léon Bérard, Lyon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Centre National de la Recherche Scientifique (CNRS) UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Department of Pediatrics, Child and Family Research Institute, University of British Columbia, Vancouver, Canada. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Oncology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Pubmed 25830658
  • Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Institut Curie, Hôpital René Huguenin, Saint-Cloud, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. · Institut Curie, Service de Génétique Oncologique, Paris, France. Inserm, U830, Paris, France. Université Paris-Descartes, Paris, France. · Université Claude Bernard Lyon 1, Villeurbanne, France. CNRS UMR 5558, Lyon, France. Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France. · Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France. · Centre François Baclesse, Unité de pathologie gynécologique, Caen, France. · Institut de Cancérologie Gustave Roussy, Service d'Oncologie Génétique, Villejuif, France. · Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique médicale et Oncogénétique, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Centre Georges François Leclerc, Oncogénétique, Dijon, France. Hôpital d'enfants, Service de Génétique Médicale, Dijon, France. · CH Georges Renon, Pôle Oncologie pour la consultation oncogénétique régionale Poitou-Charentes, Niort, France. · IPC, Département d'Anticipation et de Suivi des Cancers, Marseille, France. INSERM, UMR 912, Marseille, France. · Centre Antoine Lacassagne, Unité d'Oncogénétique, Nice, France. · Institut Claudius Regaud-IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France. · Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France. · ICL Alexis Vautrin, Unité d'Oncogénétique, Vandœuvre-lès-Nancy, France. · Hôpital Couple-Enfant, Département de Génétique, Grenoble, France. · Hôpital Universitaire Dupuytren, Service d'Oncologie Médicale, Limoges, France. · Nouvel Hôpital Civil, Laboratoire de Diagnostic Génétique, Strasbourg, France. · Groupe Hospitalier Pitié-Salpêtrière, Département de Génétique, APHP, Paris, France. · Hôpital Universitaire de Rouen, Département de Génétique, Rouen, France. · Institut Curie, Paris, France. INSERM, U900, Paris, France. Mines ParisTech, Fontainebleau, France. · Pubmed 25613119
  • IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany, on behalf of the German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC). · Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Canada. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, United Kingdom. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Genetics and Computational Biology, QIMR Berghofer, Brisbane, Australia. · Department of Pathology, University of Otago, Christchurch, New Zealand. · Department of Biomedical Sciences and Medicine, Gambelas Campus, University of Algarve, Portugal. · Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Clinical Genetics, MUMC, Maastricht, the Netherlands. · Center for Clinical Cancer Genetics, Department of Medicine and Human Genetics, University of Chicago Medical Center, Chicago, Illinois. · Department of Medicine and Institute for Human Genetics, University of California, San Francisco, San Francisco, California. · Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · Department of Epidemiology and Biostatistics, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadephia, Pennsylvania. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. · Departments of Pediatrics and Medicine, Columbia University, New York, New York. · Department of Genetics and Genomics at Case Western Reserve Medical School, Cleveland, Ohio. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology, and Transfusion Medicine Center, Dept. of Molecular and Regenerative Medicine; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Molecular Genetics Laboratory, Department of Biochemistry, Cruces Hospital Barakaldo, 48903-Barakaldo-Bizkaia, Spain. · Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. Human Genetics Group and Genotyping Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Saint Alphonsus Regional Medical Center, care of City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California. · Clinical Cancer Genetics, City of Hope, Duarte, California (for the City of Hope Clinical Cancer Genetics Community Research Network). · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, CRO Aviano National Cancer Institute, Aviano (PN), Italy. · Department of Molecular Medicine, Sapienza University, Rome, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental, and Clinical Sciences, University of Florence, Florence, Italy. · Unit of Genetic Counseling, Medical Oncology Department, Istituto Nazionale Tumori Regina Elena, Rome, Italy. · UO Anatomia Patologica Ospedale di Circolo e Fondazione Macchi, Polo Universitario Varese, Italy. · Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Aghia Paraskevi Attikis, Athens, Greece. · Dana-Farber Cancer Institute, Boston, Massachuestts. · Clinical Genetics Department, St. Michael's Hospital, Bristol, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · University of Southampton, Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, United Kingdom. · North West Thames Regional Genetics Service, Kennedy-Galton Centre, Harrow, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Leicestershire Clinical Genetics Service, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin, Ireland. St. James's Hospital, Dublin, Ireland. · All Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · Centre for Cancer Research and Cell Biology, Queens University of Belfast, Department of Medical Genetics, Belfast HSC Trust, Belfast, United Kingdom. · West of Scotland Regional Genetics Service, Southern General Hospital, Glasgow, United Kingdom. · Medical Genetics Unit, St. George's, University of London, London, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Missouri. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Germany. · Institute of Human Genetics, University Würzburg, Wurzburg, Germany. · University Heidelberg, Heidelberg, Germany. · Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany. · University Düsseldorf, Dusseldorf, Germany. · Hannover Medical School, Hanover, Germany. · Institute of Human Genetics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany. · Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne, Germany. Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Germany. · Department of Gynaecology and Obstetrics, University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein/University Kiel, Kiel, Germany. · Institute of Human Genetics, Charite Berlin, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Germany. · INSERM U946, Fondation Jean Dausset, Paris, France. Service de Génétique, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Institut Curie, Department of Tumour Biology, Paris, France. · Centre René Gauducheau, Nantes, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. · Institut Curie, Department of Tumour Biology, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, France. Institut Curie, INSERM U830, Paris, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Unité d'Oncogénétique, CRLCC Val d'Aurelle, Montpellier, France. · Department of Medical Oncology, Centre Hospitalier Universitaire Dupuytren, Limoges, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France. IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France. INSERM 896, CRCM Val d'Aurelle, Montpellier, France. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York. · Australia New Zealand Gynaecological Oncology Group (ANZGOG), Coordinating Centre, Camperdown, Australia. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois. · Ohio State University, Department of Obstetrics and Gynecology, Hilliard, Ohio. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. University of Helsinki, Helsinki, Finland. · Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, the Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, the Netherlands. · Department of Genetics, University Medical Center, Groningen University, Groningen, the Netherlands. · Department of Human Genetics, Leiden University Medical Center (LUMC), Leiden, the Netherlands. · Department of Human Genetics, Radboud University Medical Centre, Nijmegen, the Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Erasmus University MC Cancer Institute, Rotterdam, the Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, the Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Oncogenetics Group, University Hospital Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Research Institute (VHIR), Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · BMC, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland. · Unité de Recherche en Santé des Populations, Centre des Maladies du Sein Deschênes-Fabia, Centre de Recherche FRSQ du Centre Hospitalier Affilié Universitaire de Québec, Québec, Canada. · Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnessotta. · Health Sciences Research, Mayo Clinic, Scottsdale, Arizona. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnessotta. · National Human Genome Research Institute, NIH, Bethesda, Maryland. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York. · Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. · Diagnostic Molecular Genetics Laboratory, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland. · Clalit National Cancer Control Center, Haifa, Israel. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense C, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden. · Division of Clinical Genetics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, University of Cambridge, Cambridge, United Kingdom. · Sheba Medical Center, Tel Aviv, Israel. · Pubmed 25336561
2014
  • Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain. · Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain. · Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain. · Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. · Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece. · Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain. · Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain. · Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Oncology, Lund University, Lund, Sweden. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden. · Department of Oncology, Lund University Hospital, Lund, Sweden. · Department of Clinical Genetics, Lund University Hospital, Lund, Sweden. · Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America. · Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America. · Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America. · Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America. · Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America. · Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America. · Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Epidemiology, Columbia University, New York, New York, United States of America. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America. · Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America. · Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America. · Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy. · IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy. · Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy. · Department of Molecular Medicine, "Sapienza" University, Rome, Italy. · UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy. · Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. · Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. · Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom. · South East Thames Regional Genetics Service, Guy's Hospital London, United Kingdom. · Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Yorkshire Regional Genetics Service, Leeds, United Kingdom. · Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom. · West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom. · Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom. · Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom. · Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom. · Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom. · Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom. · Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom. · South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom. · North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. · Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom. · Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom. · South West Regional Genetics Service, Bristol, United Kingdom. · Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St James's Hospital, Dublin, Eire. · Cheshire & Merseyside Clinical Genetics Service, Liverpool Women's NHS Foundation Trust, Liverpool, United Kingdom. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America. · Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. · Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. · Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany. · Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany. · Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany. · Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. · Institute of Human Genetics, University of Münster, Münster, Germany. · Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. · Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany. · Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany. · Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America. · Prince of Wales Hospital. Sydney, Australia. · Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. · Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America. · For Tufts Medical Center, Boston, Massachusetts, United States of America. · Yale University School of Medicine, New Haven, Connecticut, United States of America. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. · Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands. · Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands. · Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. · Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland. · Laboratoire de Diagnostic Génétique et Service d'Onco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. · Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal. · Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia. · Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America. · Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. · Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America. · Clalit National Israeli Cancer Control Center, Haifa, Israel. · Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. · Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. · Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. · Sheba Medical Center, Tel Aviv, Israel. · Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada. · Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America. · Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain. · Pubmed 24698998
  • 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France. · INSERM U900, Mines Paris Tech, Centre de Recherche de l'Institut Curie, Paris, France. · Service de Génétique Oncologique, Institut Curie, Paris, France. · Next Generation Sequencing Platform, Centre de Recherche de l'Institut Curie, Paris, France. · 1] Service de Génétique Oncologique, Institut Curie, Paris, France [2] INSERM U830, Centre de Recherche de l'Institut Curie, Paris, France [3] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Pubmed 23942203
2010
  • UMRS 956, Université Pierre et Marie Curie, and INSERM, Paris, France. · Pubmed 21137066
2009
  • Génétique oncologique, Institut Curie-Hôpital, 26, rue d'Ulm--75248 Paris, Inserm U830, Université Paris-Descartes. dominique.stoppa-lyonnet@curie-net · Pubmed 20690207
Show More